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(B) 2/24/16 (C) 2/25/16 (D) 3/08/16 and were vertically offset for 
comparison. Tick marks for the spectra are 1 x 10-3 absorbance 
units. 
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Figure 3.26 Individual α2β2 with TTP/UDP mixing spectra in the SD region 
were collected on the following date (A) 6/09/15 (B) 6/17/15 (C) 
8/26/15 (D) 9/16/15. Tick marks for the spectra are 1 x 10-3 
absorbance units. 
139 
Figure 3.27 Individual α2β2 with TTP/UDP and HU mixing spectra in the SD 
region were collected on the following date (A) 6/09/15 (B) 
6/17/15 (C) 8/26/15 (D) 9/16/15 and were vertically offset for 
comparison. Tick marks for the spectra are 1 x 10-3 absorbance 
units. 
140 
Figure 3.28 Individual α2β2 with TTP/AzUDP mixing spectra in the SD 
region were collected on the following date (A) 12/15/15 (B) 
12/16/15 (C) 2/09/16 (D) 2/11/16 (E) 1/11/16 and were vertically 
offset for comparison. Tick marks for the spectra are 1 x 10-3 
absorbance units. 
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 Figure 3.29 Isolated β2 controls were vertically offset for comparison: (A) 40 
μM β2, 1 mM ATP, and 3 mM CDP (B) 40 μM β2, 1 mM ATP, 3 
mM CDP, and 50 mM HU (C) 40 μM β2, 1 mM ATP, 3 mM CDP, 
and 40 μM Fe(II)-AP (D) 40 μM β2, 0.8 mM TTP, and 1 mM UDP 
(E) 40 μM β2, 0.8 mM TTP, 1 mM UDP, and 50mM HU (F) 40 
μM β2, 0.8 mM TTP, and 1 mM AzUDP. 
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Figure 3.30 Individual α2β2 with ATP/CDP spectra in the water region were 
vertically offset and collected on the following date (A) 3/15/15 
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(B) 1/26/14 (C) 1/27/14 (D) 1/29/14. Tick marks for the spectra 
are 2 x 10-3 absorbance units. 
Figure 3.31 Individual α2β2 with ATP/CDP and HU spectra in the water 
region vertically offset and collected on the following date (A) 
3/15/15 (B) 1/26/14 (C) 1/27/14 (D) 1/29/14. Tick marks for the 
spectra are 2 x 10-3 absorbance units. 
144 
Figure 3.32 Individual α2β2 with ATP/CDP and Fe(II)-3AP spectra in the 
water region were vertically offset and collected on the following 
date (A) 2/24/16 (B) 2/25/16 (C) 3/08/16. Tick marks for the 
spectra are 2 x 10-3 absorbance units. 
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Figure 3.33 Individual α2β2 with TTP/UDP spectra in the water region 
vertically offset and collected on the following date (A) 6/09/15 
(B) 6/17/15 (C) 8/26/15 (D) 9/16/15. Tick marks for the spectra 
are 2 x 10-3 absorbance units. 
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Figure 3.34 Individual α2β2 with TTP/UDP and HU RIFT-IR spectra in the 
water region vertically offset and collected on the following date 
(A) 6/09/15 (B) 6/17/15 (C) 8/26/15 (D) 9/16/15. The spectra were 
offset along the y-axis for comparison. Tick marks for the spectra 
are 2 x 10-3 absorbance units. 
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Figure 3.35 Individual α2β2 with TTP/AzUDP spectra of the water region 
vertically offset and collected on the following date (A) 12/15/15 
(B) 12/16/15 (C) 2/09/16 (D) 2/11/16 (E) 1/11/16. Tick marks for 
the spectra are 2 x 10-3 absorbance units. 
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Figure 3.36 Individual isolated β2 controls in the water region were vertically 
offset for comparison: (A) 40 μM β2, 1 mM ATP, and 3 mM CDP 
(B) 40 μM β2, 1 mM ATP, 3 mM CDP, and 50 mM HU (C) 40 
μM β2, 1 mM ATP, 3 mM CDP, and   40 μM Fe(II)-AP (D) 40 
μM β2, 0.8 mM TTP, and 1 mM UDP (E) 40 μM β2, 0.8 mM TTP, 
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SUMMARY 
Ribonucleotide reductase (RNR) catalyzes the production of deoxyribonucleotides 
in all cells. RNR is a multiple subunit enzyme responsible for supplying cellular 
deoxynucleotide triphosphate (dNTP) pools by using radical based chemistry to convert 
nucleotides to the corresponding deoxy forms, the only pathway for de novo synthesis of 
the building blocks for both DNA replication and DNA repair. In E. coli class Ia RNR, a 
transient 2β2 complex forms when a ribonucleotide substrate binds to the 2 subunit.  A 
tyrosyl radical (Y122O•)-differic cofactor in β2 initiates substrate reduction in 2 via a 
long distance, proton-coupled electron transfer (PCET) process generating a thiol radical 
located an astonishing 35Å away in the active site of the functional α2β2 complex. In this 
work, I use reaction-induced FT-IR spectroscopy to describe the 2β2 structural 
landscapes associated with catalysis and inhibition by anti-cancer chemotherapeutics.  E. 
coli 2 and β2 mixing was performed with a substrate, CDP/UDP, and the appropriate 
allosteric effector, ATP/TTP.  Isotopic labeling was implemented to define subunit-specific 
structural changes.  Mixing of 2 and β2 subunits to form the active complex yielded amide 
I (C=O) and II (CN/NH) bands indicative of structural rearrangements associated with 
catalysis. The distinctive inhibitor, AzUDP, lifts the veil of the conformational mask 
accompanying proton-coupled electron transfer (PCET) to generating a nitrogen radical 
that is moderately stable. AzUDP demonstrates backbone rearrangement associated with a 
redox-induced shift between Y122OH and D84 as well as conformational dynamics linked 
to radical generation in the  subunit. Inhibitor-mediated reduction of Y122O• was 
associated with structural changes in 2, as well as β2. To define the spectral contributions 
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of tyrosyl radical reduction in the quaternary complex, 2H4 labeling of β2 tyrosines and 
HU-editing were performed.  These spectra provide evidence for a conformational 
rearrangement at a second β2 tyrosine(s), Yx, in the 2β2 complex.  To develop new drugs, 
information concerning the mechanism is critical. To obtain information, a more specific 
comprehension of the radical’s complete cycle must be achieved. FTIR spectroscopy 
allows for the detection of single amino acid changes that take place as a result of RNR 
inhibition due to radical quenching or trapping. The FTIR spectra highlight the distinction 
between substrates and effectors during active turnover, and the conformational impact of 
inhibition during active turnover of the QC. 
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CHAPTER 1. INTRODUCTION 
1.1 Ribonucleotide reductase 
Ribonucleotides are produced from simple building blocks that consist of amino 
acids, tetrahydrofolate derivatives, NH4+, CO2 and 5-ribosyl-1-pyrophosphate. No 
additional pathway has evolved for the production of deoxyribonucleotides, and no 
separate de novo pathway exists to produce deoxyribonucleotides without ribonucleotide 
reductase (RNR).1 RNR reduces all four of the ribonucleotides to the corresponding 
deoxyribonucleotides, it is an essential enzyme in cellular growth for DNA synthesis and 
repair. The reduction process of ribonucleotides to deoxyribonucleotides proceeds through 
a conserved PCET pathway.2 For DNA synthesis and repair to occur in cells, 
deoxyribonucleotides must be made readily available. RNR is the only enzyme capable of 
synthesizing and maintaining nucleotide pools. The salvage pathway can recover the purine 
and pyrimidine bases from DNA degradations which can be used to reform their 
nucleotides by phosphoribosylation.3 However, the salvage pathway is unable to produce 
the deoxynucleotides needed for DNA synthesis and repair which can only be 
accomplished by RNR.3-4 RNR, seen in Figure 1.1, is categorized into three classes. Each 
class uses a free radical to reduce the nucleotide substrate.1, 5 The free radical is formed on 
a conserved cysteine amino acid residue in the active site of the enzyme. The free radical 
abstracts a hydrogen at the ribose 3′-carbon of the nucleotide.6-7 The 2′-hydroxyl group is 
eliminated as H2O leading to the formation of a disulfide bond between two conserved 
active site cysteine residues (225 and 462, E. coli). This mechanism is discussed further in 
section 1.1.4. For rapid catalysis to proceed, reduction of the disulfide bond must be 
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completed by thioredoxin (TR) or glutaredoxin (GR).8 These two small proteins reduce the 
disulfide bond formed during deoxynucleotide production to allow turnover to continue. 
Without TR/GR reducing these conserved cysteine residues, RNR can only perform 
reduction of four nucleotides reactions before conserved cysteines require reduction of the 
disulfide bonds by thioredoxin reductase (TRR) or glutaredoxin reductase (GRR).9  
 
Figure 1.1 (A) 3.2 Å crystal structure α2 subunit with TTP effector (red) and GDP 
substrate (orange). The α2 subunit houses the active site for substrate turnover (PDB 
4R1R).  (B) 2.2 Å crystal structure (2XOF) β2 subunit with the diiron clusters 
responsible for radical generation shown in brown (iron) and red (oxygen). Substrate 
and effector binding sites are highlighted above: active site (green), specificity site 
(red), and iron cluster (blue).10-12 
 Ribonucleotide reduction retains a central role in the regulation of the cellular 
concentrations of the four dNTPs required for DNA synthesis. Maintenance of precise 
concentrations is essential for DNA synthesis fidelity.13-14 These small dNTP pools suffice 
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in mammalian cells for only a few minutes of DNA replication and must therefore be 
renewed continuously during S-phase.15 Cells not in S-phase are capable of synthesizing 
dNTPs de novo, albeit at a much slower rate due to decreased concentrations of RNR.16  
Due to the variable demands for dNTPs based on the given phase of the cell, the overall 
expression of RNRs is linked to the cycle of cell-division. Expression of the enzyme is 
increased during periods of cell growth while maintaining low levels of expression during 
cellular equilibrium.17 Because RNR plays such a pivotal role in cell growth and division, 
it has remained a key target for pharmaceuticals that aim to inhibit its function.18-19 
Inhibition of the enzymatic function of RNR is attributed to its overexpression in rapidly 
multiplying cells and  its association to tumor cells.19-26  
RNR was the first protein discovered to house a stable radical.27-30 The 
methodology by which ribonucleotide reduction occurs was unprecedented when first 
discovered.31 Long-range proton-coupled electron transfer (PCET) system allows the 
radical hole to migrate 35 Å into the active site for nucleotide reduction.30 Hypotheses 
detailing the mechanism of RNR remained clouded until high-resolution crystal structures 
of E. coli and mammalian class Ia RNR were solved.10-12, 32-33 These crystal structures 
provided insight for researchers to explore the method of radical generation and subsequent 
propagation into the active site.27, 34-36 They further provided physical evidence for theories 
based on allosteric regulatory effects concerning substrate reduction.12, 37-41  
Free radicals are defined as any molecule with an uneven number of electrons in its 
valence shell.42 Free radicals are highly reactive and can be generated in vivo as by-
products of ordinary metabolism or from ecological factors.43-44 For instance, the 
mitochondrial electron transport chain provides the primary source of ATP in the cell.45 
 4 
During this process, electrons could exit the respiratory pathway preceding water formation 
and react with molecular oxygen resulting in the formation of superoxide (O2-), however, 
this is not normally expected.45 Superoxide is toxic and has been associated with numerous 
disorders.46 Overproduction of reactive oxygen species (ROS) accompanied with 
deficiencies in antioxidants leads to oxidative stress.47 Radical cause oxidative stress by 
interacting with vital cellular components like DNA or cellular membranes, so they are 
highly destructive if not properly regulated.48-49 The overall impact of ROS on cellular 
mechanisms is reliant on the period of exposure and the total oxidative strength of the 
radical species.50 The cell contains an assortment of other safeguards when facing oxidative 
stress due to the likelihood of exposure.51-52 Free radicals can be formed internally through 
natural processes or externally by radiation, medications, or pollution. Because it is not 
possible to measure free radicals in the body, the by-products are measured in response to 
oxidative stress.53  
Antioxidants reduce cellular damage due to free radical reactivity by safely 
nullifying radical species before irreversible damage is triggered. The most widely studied 
antioxidant enzymes include superoxide dismutase (SOD) and glutathione reductase.43, 54 
Antioxidants are capable of destroying free radicals in one of two ways, either chain 
breaking or prevention.54-55 Radical formation is accompanied by the less or gain of 
electron. In the second case, an additional radical was also formed. The formation of the 
highly reactive radical species will result in a chain reaction of unstable products. This 
process will proceed throughout the cell(s) until either the radicals are quenched by a chain 
breaking antioxidant (vitamin C, carotenoids, etc.) or by radical-radical reaction leading to 
radical termination.56-57 Preventative antioxidants can avert the original chain reaction by 
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scavenging the initiating free radicals.55 In either case, the antioxidant becomes oxidized 
and must be restored or new antioxidants must be produced. If a disproportion occurs 
between ROS and their antioxidant counters, irreparable damage can follow.58 For 
example, a hydroxyl radical interacting with DNA can result in damage to the deoxyribose 
backbone and purine and pyrimidine bases.42 The oxidative damage that results from this 
radical reaction leads to permanent modifications of the DNA sequence leading to 
mutagenesis and carcinogenesis in the system. When excessive concentrations of ROS are 
formed, they can have deleterious properties, however, free radicals are not merely 
associated with harmful consequences. At low/moderate levels, ROS can actually be 
advantageous and even necessary for certain biological activities. Phagocytes, for instance, 
target infecting microbes by means of radical species.59 The radicals target and destabilize 
the cellular membrane acting as a biological defense mechanism.60 Biological systems also 
utilize ROS in cellular signaling pathways such as nonphagocytic NADPH oxidase.61 This 
enzyme is the key in regulating intracellular signaling cascades. Ribonucleotide reductase 
is one such enzyme that uses an organic free radical to catalyze the biosynthesis of 
deoxyribonucleotides for DNA synthesis.6  
1.1.1 Classes of RNR based on metallo-cofactors 
Ribonucleotide reductases can be assembled into three main classes as seen in Figure 
1.2.5, 37, 62-63 As is the case in each of these classes, all use radical-based chemistry for 
overall nucleotide reduction, but can be catalogued based on metallo-cofactors, aerobic vs. 
anaerobic, and catalytic state. Class I RNRs consist of two homodimeric proteins, 2, 
coded by the nrdA gene, and 2, coded by the nrdB gene. The α subunit contains the 
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catalytic site (or active site) and binding sites for allosteric effectors (the activity site and 
the specificity site). The  subunit contains an oxygen-linked diferric cluster and a stable 
tyrosyl free radical.64 Class I RNR is further subcategorized based on the metallo-cofactor 
required for radical initiation.7 Class Ia, Ib, and Ic consist of Fe3+-O-Fe3+, Mn3+-O-Mn3+, 
and Fe3+-O-Mn4+ clusters, respectively. In class Ia and Ib, thiyl generation in the active site 
is induced by allosteric regulators binding to the α subunit that induces structural dynamics 
allowing the radical hole from the  subunit to be transferred.33, 38-40, 65-67 However, class 
Ic uses a phenylalanine in the place of tyrosine and a Fe3+-O-Mn4+  cluster to generate the 
radical.62 Class Ia RNRs are found in mammals and E. coli, and has two sites of allosteric 
regulation, the specificity site and the activity site. Both sites are located in the 2 dimer.5 
Class Ib is restricted to only certain bacteria and only contains one site of allosteric 
regulation.39 In class Ia, RNR is inhibited when dATP binds to the activity site in the N-
terminal domain.40 Class II uses a radical adenooxylcobalamine to initiate radical 
generation.68 The anaerobic class III’s  subunit is coded by nrdD and contains a stable 
oxygen-sensitive glycyl radical. The  subunit is coded by nrdG, and contains an iron-
sulfur cluster that with S-adenosylmethionine can generate the glycyl radical needed for 
nucleotide reduction.69  
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Figure 1.2 The three classes of RNR characterized by the mechanism they use for 
radical generation and on their structural differences. These classes are responsible 
for the generation of the cysteine radical in the  subunit active site.19, 47 
 To produce the fundamental tyrosyl radical in the class Ia E. coli 2 dimer, first the 
iron cluster must be constructed. The biosynthetic pathway for radical generation is limited 
by structural rearrangements and provides a method to control overall RNR activity.70 The 
details of the metallo-cofactor formation are shown in Figure 1.3. The functional 2 
enzyme is formed after the Fe2+-2 is oxidized by molecular oxygen (O2) using amino acid 
residue tryptophan 48 as a reductant.29 Four total electrons are necessary to fully reduce 
molecular oxygen. The two ferrous ions donate one electron each, with the third coming 
from Y122, and the fourth being provided from the aforementioned W48.71-72 In E. coli 2, 
YfaE is a gene downstream of nrdB (encoding for 2) that codes for a putative ferrodoxin. 
It is hypothesized to be directly involved in the biosynthetic and maintenance pathways for 
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iron cluster formations. YfaE was isolated and reconstituted with 80% of its iron in 
[2Fe2S]+ and the remaining 20% in [4Fe4S]2+.73 In vitro kinetic studies provide evidence 
that YfaE is kinetically proficient enough for reduction of the diferric cluster to the 
diferrous form, as well as deliver the required reducing agent in the biosynthetic pathway. 
When reductants are introduced to the active, radical containing 2, the tyrosyl radical can 
be scavenged forming the met2 state (diferric site and non-oxidized Y122). The reduced 
2 can be formed when met2 is exposed to external reductants in vivo.74-75 
 
Figure 1.3 RNR Class Ia E. coli proposed biosynthetic and maintenance pathways for 
the diferric metallo-cofactor.27-28, 36-37 
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 In assembling the diiron unit, the cluster and the environment surrounding 
the cluster, including metal bound ligands, go through various states during the lifecycle 
of RNR.32, 76-77 Intermediate X shows this in Figure 1.3. Understanding the mechanism of 
oxygen activation requires knowledge of the reduced 2, and there is still much that 
remains unclear about the biosynthetic pathway of the diferric metallo-cofactor. One such 
example are the ligands that stabilize the metal cluster and the environments surrounding 
those ligands. Ser211 is a highly conserved amino acid located on the opposite side of the 
helix to Glu204. Mutation of the residue to alanine (S211A) was implemented as a probe 
to determine if a proposed interhelical hydrogen bond was vital for iron assembly and 
maintenance, while being so far displaced from the iron center. There was a noticeable 
conformational change from residues 208-215, and the diferric site has a much slower rate 
of reduction, while being more susceptible to radical scavenger hydroxyurea (HU) when 
compared to the wild type.77-78 
 A methodology was established using hydrogen peroxide to generate the tyrosyl 
radical in 2 crystals to observe potential conformational changes between the active and 
reduced states. This was characterized by electron paramagnetic resonance (EPR) 
spectroscopy and discussed in comparison with a 1.42 Å x-ray crystal structure of the 
met2.79 The -oxo linked irons of the oxidized center are coordinated by four carboxylates 
and two histidine residues. The diferric cluster is proposed to undergo conformational 
changes during reduction of the 2 radical. These structural changes allow the iron center 
to be accessible to oxygen to allow the reformation of the active enzyme.64 The reduced 
form of 2 and the apo-2 have similar structures overall. Coordinating iron bound ligands 
have relatively small differences in position in the apo-2 protein which sees the side 
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chains collapse in to occupy the space left by the dinuclear iron site.76 These small 
modifications are attributed to minimizing the reorganization energy for iron 
reincorporation.  
1.1.2 RNR class Ia E. coli subunits 
The larger  subunit (86 kDa) is where nucleotide reduction occurs. The subunit 
encompasses the activity site, responsible for triggering the enzyme and starting radical 
transfer into the active site, the specificity site, which influences what substrate binding to 
the active site where nucleotide reduction takes place.38-39, 66, 80-81 These two allosteric 
regulation sites (activity and specificity sites) allow the cell to maintain the proper ratio of 
deoxyribonucleotides available for DNA synthesis.82-83 The monomer is composed of the 
N-terminal, predominantly helical domain (220 residues), a novel ten-stranded / barrel 
(480 residues), and a  domain (70 residues).11-12, 76 The active site is where the 
transient cysteine radical is generated and is buried within the enzyme but remains close to 
the C-terminus of 2. Substrate analogs, such as AzidoUDP (AzUDP), were employed to 
trap the radical in the active site during substrate turnover to observe the active site radical. 
This resulted in the stoichiometric loss of Y122• content accompanying the formation of a 
substrate analog radical observed by 9 and 140 GHz EPR spectroscopy.84-85 The pathway 
that the radical takes to the active site was also examined with the radical trap, 3-
aminotyrosine (Y731NH2Y-2  and Y730NH2Y-2). This was the first direct evidence of a 
radical intermediate on the proposed radical pathway during turnover.86 The two allosteric 
regulation sites in the  subunit were established in the crystallographic studies with 
adenosine‐5′‐(β,γ‐imido) triphosphate (AMP‐PNP), a non‐hydrolyzable analogue of ATP 
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in the activity site and TTP in the specificity site.39 Activity in RNR is cell cycle dependent 
in higher organisms where it is transcriptionally regulated and activity is subject to the 
binding of ATP and dATP for catalysis and inhibition, respectively.17 The specificity site 
is located at the interface between the  monomers. This distance between the specificity 
site and the activity site is ~15 Å, so direct interaction seems unlikely. However, the 
effector, seen in Figures 1.1 and 1.4, stabilizes 3 highly flexible loops, referred to as Loops 
1, 2, and 3, which facilitate communication with the substrate binding site. Loops 2 forms 
hydrophobic interactions with the base of the effector. These interactions influence the 
positions adopted by Loops 1 and 3 as a result.39 Allosteric effectors have shown substantial 
control of RNR regulation which can modulate oligomerization based on regulation sites 
located 42 Å from the active site. These allosteric effectors demonstrate dramatic subunit 
rearrangements. Allosteric regulation of activity provides a mechanism to prevent the 
accumulation of cytotoxic levels of deoxyribonucleotides by communicating with the 
substrate-binding site. Structural evidence suggests the rearrangement of subunits based on 
binding by effectors.87 
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Figure 1.4 Crystal structure of the 2 subunit loop interactions with the effector 
bound TTP (red) to the specificity site. (PDB 4R1R). 
In 1990, the work by Nordlund and coworkers presented a structure of class Ia RNR 
that provided information regarding the structure and function of the diiron cluster.32 The 
smaller  subunit (45 kDa) houses the tyrosyl radical (Y122•) generated by the 
aforementioned metal cluster. Y122 was shown to be near the iron cluster, buried deep in 
a hydrophobic environment.31 To date, several high-resolution crystal structures have been 
solved. These include different forms of class Ia E. coli,10-12 mouse,88 human,89 and human 
p5390 RNRs. The crystal structure of E.coli and murine RNR have similar coordination 
around their diferric cluster, but the murine RNR communicates with the solvent by a 
narrow hydrophobic channel and is less shielded than E.coli which would explain its higher 
susceptibility to cancer therapies.91 Each 2 subunit is composed of 13 -helices and 2 -
sheets. Due to its increased flexibility, the last 35 amino acid residues of the C-terminal tail 
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have not been resolved in the 2 crystal structure.92 As it is located 35 Å from the catalytic 
site in the  subunit, Y122• is not directly participating in ribonucleotide reduction. 
Because of this vast distance between where the radical is produced and where the transient 
radical initiates substrate reduction, the process by which RNR completes this transfer was 
investigated. Early studies involved simple mutations of Y122 to a phenylalanine were 
performed in E. coli which resulted in the loss of all catalytic ability.93 These findings are 
consistent with the understanding of radical introduction by the metallo-cofactor. Based on 
crystal structures, it was made clear that the diiron cluster needs Y122 to generate the 
radical required for substrate reduction. Accompanying site specific mutations were used 
in residues that were shown to be conserved in class Ia RNRs to determine the mechanism 
behind radical transfer. Mutation of Y356 was performed with the use of orthogonal tRNA 
synthases with 3-,4-dihydroxyphenylalanine (DOPA), a radical trap. The observed loss of 
Y122• was met with the formation of a new radical intermediate when DOPA356Y-2 
was mixed under catalytic conditions.94 PELDOR spectroscopy was used to measure the 
distance between Y122• in one : pair and the proposed formation of DOPA356• in the 
neighboring : pair to compare with EPR spectroscopy and crystal structures. The relative 




Figure 1.5 UV-Vis absorbance spectroscopy of E. coli 2. Y• is identified by a sharp 
peak at 410 nm with a shoulder at 390 nm. Iron contributions are detected at 325 and 
375 nm. 
  Typically, free radicals are short lived due to their high reactivity.96 This is not the 
case for Y122• that displays an unusually stable tyrosyl radical that can be stored until 
radical transfer is initiated by ATP binding to the activity site.34 The increased stability is 
hypothesized to be linked to Y122 residing within a hydrophobic pocket 10 Å from the 
surface and is apparently inaccessible to solvent.97 Mutations to small channels where 
Y122 is exposed to the protein surface has displayed an increased sensitivity to radical 
scavengers.98  During 2 purification,99 protein concentration is determined by UV-Vis 
spectroscopy at 280 nm. Determination of the tyrosyl radical concentration is more 
involved due to the nature of the radical spectrum in Figure 1.5. The tyrosyl radical peak 
(410 nm) has a sloping baseline, so to combat this,  a baseline drop down method is used:71 
[Y•] =  
𝐴411𝑛𝑚 − [






1.1.3 Regulation of RNR 
As stated above, RNR turnover is regulated by the binding of dATP to the activity 
site so that when elevated levels of dATP are present in the cell, the enzyme becomes 
inactive.78, 81 Another tool that the cell uses to regulate RNR functionality is the cell cycle. 
In mammals, RNR activity reaches its maximum during the S-phase.100-101 As the cell exits 
the S-phase and enters G2 phase, RNR is targeted by two ubiquitin ligases and the enzyme 
is degraded.102 While small concentrations  and  subunits remain present during G0/G1 
for DNA repair, transcription is minimal during these phases of the cell cycle.103 Not only 
does the cell’s ability to direct transcription and degradation allow for an additional means 
for regulatory control, but also the localization of RNR in the cell reinforces that strictness. 
RNR proteins are located predominantly in the cytoplasm where dNDPs are produced and 
diffuse into the nucleus during DNA synthesis.104-105 Contrary to this, increasing studies 
have displayed  and  are translocated into the nucleus in response to DNA damage.106-
107 Understanding this process has just begun and innovative new studies will be needed to 
fully link RNR translocation into the nucleus.  
1.1.4 Nucleotide reduction 
Despite the divergent evolutionary pathways leading to the rise of multiple classes 
and subclasses of ribonucleotides reductase, this work focuses on class Ia and the 
mechanism of ribonucleotide reduction in it. The ribonucleotide reduction mechanism in 
Figure 1.6 was proposed based on mechanism-based inhibitors such as [3'-3H]NDPs and 
2'-halogenated ribo- and arabinonucleoside triphosphates demonstrated C-H bond cleavage 
and the importance of the 2'-group of the ribose.108-110 This led to the theory that the 
 16 
transient thiyl radical was removing the 3'-hydrogen of the nucleotide.111  Deduction of 
further steps were based upon model reactions involving ethylene glycol dehydration.112-
113  
 
Figure 1.6 Proposed mechanism for nucleotide reduction of class Ia E. coli RNR.2, 89 
 Figure 1.6 illustrates the proposed mechanism for nucleotide reduction.114 The 
overall reaction is initiated by binding of substrates and effectors to the 2 dimer. This 
leads to long-range PCET and transfer of the radical hole into the active site to generate 
C439•. The transient radical abstracts a hydrogen atom from the 3'-carbon and generates a 
substrate radical. The substrate radical facilitates the leaving of the protonated OH group 
at the 2'-carbon as H2O. The redox-active cysteine pair (C225 and C462) reduce the 
substrate radical and briefly forms a cysteine radical at the newly formed disulfide bond. 
At this point, the hydrogen atom stored at C439 is returned to the 3'-carbon by regenerating 
the thiyl radical. For turnover to continue, conserved cysteine residues (C754 and C759) 
must reduce the disulfide bond formed in the active site during ribonucleotide reduction. 
After this is complete, the  subunit continue providing dNDPs for DNA replication.115 
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RNR requires small proteins, thioredoxin (TR) and glutaredoxin (GR) that contain redox-
active thiols, to reduce disulfide bond formation that occurs during turnover. NADPH 
reduces the cysteines of the redoxins with specific thioredoxin reductase or glutathione and 
glutathione reductase.8, 116 
1.2 The radical propagation pathway 
1.2.1 Incorporation of unnatural amino acids 
Multiple allosteric sites have been observed for E. coli 2.38-39 These allosteric sites 
initiate substrate reduction and transfer of the radical hole into the active site. In the pursuit 
of a radical transportation pathway (Figure 1.7), initial experimentation involved mutation 
of conserved residues in the : subunits and the measuring of activity to determine key 
amino acid residues related to the function of RNR. A few of those mutations are: Y122F,93 
W48F,117 Y356NO2Y,118 Y731F, and Y730F.119  These mutations are at universally 
conserved residues and resulted in the loss of catalysis in the holoenzyme suggesting that 
these residues must play some role in nucleotide reduction or assembly of the diiron 
cofactor. The use of radical traps for these conserved tyrosine residues were used. 
DOPA356-2, NH2Y731-2, and NH2Y730-2 mutants were monitored using stop-flow 
UV-VIS,120  EPR,86 and PELDOR spectroscopy.86, 95  These experiments were the first 
direct evidence of radical formation in the proposed radical hopping pathway.  
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Figure 1.7 The proposed radical transfer pathway in E. coli RNR. Distances in the 2 
subunit are from an oxidized crystal structure.23 Note that due to the disordered C-
terminal tail in the 2 subunit, the position of Y356 is unknown.61, 71-72, 89, 97-98 
The radical pathway was further manipulated using the perturbation of reduction 
potentials along the electron transfer pathway to accumulate the radical state outside of the 
normal Y122. Mutation of Y122 to a NO2-Y122 was previously shown to retain activity 
catalyzing the formation of 0.6 equivalents of dCDP and 0.6 equivalents of a newly formed 
radical species.121 Retention in activity is expected as the mutation remove the phenol 
group like previous mutations with phenylalanine. However, the reduction potential is 
significantly higher than the native Y122. Meaning that once the nucleotide (CDP) is 
reduced (dCDP), the radical is unable to regenerate Y122• and the radical accumulates in 
the lowest energy state.  
1.2.2 Hydrogen bond formation between Y356 in E. coli 2 and water molecules from 
the interface 
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Tyrosine-356 is the last proposed aromatic amino acid in the radical transfer 
pathway within the 2 subunit and it is the only proposed residue that cannot be observed 
structurally.122 Mutation of Y122 to NO2Y122 disables functioning catalysis by 
dramatically raising the reduction potential by +200 mV at Y122. This site-directed mutant 
prohibits the reformation of Y122• and synthesis of deoxyribonucleotides is unable to 
proceed until the radical is regenerated at Y122. PELDOR spectroscopy experiments reveal 
85-90% of the radical had accumulated at Y356 in 2 and the remaining 10-15% was 
delocalized over Y731 and Y730 in 2 as a result of increased reduction potential at Y122 
not allowing reformation of the radical resting state.123 These results confirm the radical 
species generation previously reported along the radical pathway. For nucleotide reduction 
to occur, the 2 subunit and the 2 subunit must associate with one another in the presence 
of substrates and effectors and the radical must pass between the : interface. This 
interface is highly sensitive and can be influenced by single point mutations.65 Efforts have 
been made to understand the radical chemistry happening across the interface. In Figure 
1.7, substitution at Y356 of the  subunit interface with 2,3,5-fluorotyrosine and the 
ensuing interactions with wt-2, Y731F-2, and Y730F-2 using high field (263 GHz) 
EPR and ENDOR revealed hydrogen bonding to Y356•.124 Two water molecules from the 
interface were observed coordinating to the tyrosyl radical. Y730F-2 mutations revealed 
that Y731 is able to form one hydrogen bond with the interface and the formation of this 
hydrogen bond leads to a change in the electrostatic environment of Y356. Based on these 
results, there seems to be evidence that Y356 and Y731 are able to communicate across the 
subunit interface through hydrogen bonding interactions.125 
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Figure 1.8  and  communication across the : interface via hydrogen bonding 
interactions. 
1.2.3 Hydrogen bonding network in E. coli 2 
For catalysis to occur, a transient cysteine radical must be formed in the 2 active 
site.1 The use of photo-active peptides has further elucidated electron transfer (ET) between 
Y356 and the mechanism by which the radical takes to the active site in the 2.126 These 
peptides mimic the final 20 amino acids residues of the 2 C-terminal tail where a photo 
trigger is located directly adjacent to Y356. Radical initiation is promoted by Xe lamp 
irradiation (   300 nm) and association of the peptide to the 2 dimer with 14C-CDP and, 
allosteric effector, ATP display turnover via Y731, Y730, and C439.127-128 Development 
of photoRNRs have replaced the conserved Y356 residue with tryptophan. This 
substitution yields a 3-fold increase in radical content. Typically, substitution of Y356 has 
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resulted in little to no enzymatic activity.129 The use of this Y356W photo-oxidant 
maintains 20% of turnover capabilities relative to wt-2.130 Further analysis was focused 
on the specific interactions along the radical propagation pathway in the  subunit. 3-
aminotyrosines were site-specifically incorporated at Y730 and Y731. ENDOR, DFT 
calculations and multi-frequency EPR data reports the detection of a single strong 
hydrogen bond with NH2Y731• and one strong and one moderate hydrogen bond identified 
with NH2Y730•.131-132 In Figure 1.8, alteration of the pathway using amino acid residues 
that have been shown to inactive the pathway, Y731F and Y730F,119 resulting in the loss 
of the strong hydrogen bond interaction in both tyrosines. The data suggests that the strong 
hydrogen bond is a result of these two tyrosines hydrogen bonding to one another and that 
the proton between the tyrosines is transferred by collinear proton-coupled electron 
transfer. DFT calculations report that C439 is within hydrogen bonding distance to Y730. 
Mutation of the active site cysteine to alanine, C439A, result in loss of the second moderate 
hydrogen bond reports with NH2Y730•. Despite these findings, it remains entirely possible 
that water acts as the moderate hydrogen bond and that mutation of the cysteine results in 
disruption of the water network. X-ray structures of the NH2Y- reveal that the hydrogen 
bonding network remains unperturbed in comparison to the wild-type.  
Furthermore, ruthenium complexes have been established to study long-range 
electron transfer reactions in functioning enzymes.133-135 The photophysical characteristics 
of ruthenium has been advantageous in the catalytic capabilities of metalloenzymes in 
particular. Ruthenium complexes are proficient in flash photolysis to catalyze redox 
reactions. To study a tyrosyl radical in a natural protein environment, a ruthenium complex 
was designed to generate a tyrosyl radical by flash photolysis to study intramolecular 
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electron transfer.136 Ruthenium photosensitizers are able to initiate electron transfer in 
complex enzymes containing site specific mutations. This permits for the direct analysis of 
electron transfer rates. A similar complex was designed by the Stubbe group, where they 
site-specifically incorporated a rhenium complex directly adjacent to Y356 in the 2 
subunit.137 With the Re-complex, direct observation of proton and electron transfer across 
the / interface was observed. By removing Y122 from the equation direct ET and PT 
transfer can be detected along the PCET pathway in the individual subunit, as well as, 
between the two subunits.   
1.2.4 Thermodynamic landscape of radical pathway 
Other classes of RNR initiate radical reduction and hydrogen atom abstraction from 
the ribonucleotide using their cofactors to generate the radical species.1, 138 By doing so, 
these other classes avoid long-range radical transfer. Evolution has driven class Ia RNR to 
develop this mechanism, but what overall benefit does it provide? Implementation of 
NO2Y122• acts as a thermodynamic block and in place of Y122• is 200 mV more 
oxidizing.118 Radical traps further deviate typical reduction potentials in conserved 
residues to expose exquisite kinetic control over radical initiation. Amino acid derivatives 
allow for the exploitation of their properties with redox potentials that range from -50 to 
+270 mV and pKAs from 5.6 to 7.8 relative to that of tyrosine. By adjusting the redox 
potentials, radical transfer becomes the rate limiting step so that other activity regimes can 
be observed. This data provides support for the proposed involvement of redox active 
sites.94 In Figure 1.9 A, reduction potentials of pathway moieties are organized to examine 
the role that reduction potentials play in radical transfer. From Figure 1.9 A, the process of 
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initiating the radical in the active site is observed to be ~200 mV uphill. Reduction 
potentials were measured using ∆𝐸° =  
𝑅𝑇 ln 𝐾𝑒𝑞
𝑛𝐹
, where Keq = [Y356•]/[ F3Y122•], R is the 
ideal gas constant, T is the temperature, n is the number of electrons being transferred, and 
F is Faraday’s constant.139-140 Figure 1.9 B are the unnatural amino acids involved in the 




Figure 1.9 Unnatural amino acid incorporation into universally conserved amino 
acids in RNR. (A) Thermodynamic landscape of RNR radical pathway. (B) List of 
unnatural amino acids used to date that have been substituted into 2 or 2 to 
determine radical transport into the active site.86, 94-95, 118, 120, 141-142 
1.3 Inhibition 
In Figure 1.7, there are a sequence of conserved amino acid residues that have been 
proposed to be part of an electron transfer hopping pathway.1, 15 This pathway has been 
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supported by the incorporation of unnatural amino acids at conserved residues in the 
passageway that has resulted in complete inactivation of the RNR enzyme or accumulation 
and detection of newly formed radical species outside of Y122 as discussed previously.86, 
127 In the pursuit of revealing the complicated mechanism surrounding RNR, we set out to 
explore the pharmaceutical implications on RNR. The main focus of this work will be the 
examination of inhibitors that target the 22 active quaternary complex (QC) to prevent 
nucleotide reduction by radical scavengers quenching the tyrosyl radical and using 
substrate analogs to trap the radical in the active site in the aim to uncover new information 
concerning therapeutic inhibition.  
1.3.1 Hydroxyurea 
Hydroxyurea (HU) is commonly used for the treatment of myelogenous leukemia 
and has been supported as a cancer therapy for decades due to its direct quenching of the 
tyrosyl radical in RNR.143-144 In fact, HU is the only inhibitor that is used to clinically 
neutralize RNR activity. HU was first synthesized in 1896,145 buts its clinical use was not 
discovered until the 1960s.37, 146-147   The method of hydroxyurea reduction of the tyrosyl 
radical could be feasible by direct interaction. Another possible method is, HU, being a 
small molecule, is able to gain access through small channels leading to the site of radical 
generation. Another potential route would be long-range electron transfer from the surface 
of the enzyme.148 A group of three conserved cysteines provide a means of electron transfer 
from the surface of 2 to the radical resting state to allow for indirect radical quenching 
from the surface. However, the effectiveness of HU is limited by its low affinity for RNR, 
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the cells ability to develop resistance, short half-life, small molecular size, and very high 
hydrophilicity.37, 149-152  
1.3.2 Triapine 
Triapine has shown promising results in actively targeting RNR and quenching the 
tyrosyl radical in a similar mechanism to HU, but is vastly more potent.153-155 Triapine can 
significantly inhibit overall RNR activity in leukemia, non-small cell lung cancer, renal 
cancer, and increase radiation-mediated cytotoxicity in cervical cancer and colon 
cancer.154, 156-160 Triapine has shown the most promise as an inhibitor of RNR activity from 
a group of thiosemicarbazones derivatives whose competency was tested via 
deoxyribonucleotide triphosphate concentrations and analysis of cell count as a function of 
time.161 The mode of inhibition of Triapine has been greatly debated. It was proposed that 
Triapine chelates iron directly from the diiron cluster in 2 while another suggested that 
the iron was chelated from intracellular pools, drastically lowering iron concentrations, 
which inhibited the formations of the metallo cofactor.162-163 The current model in the 
literature attributes Fe(II)-3AP as the active form in vitro and is active against HU resistant 
tumor cells by quenching the tyrosyl radical.37 Introduction of Fe(II)-3AP to cancerous 
cells have exhibited increased cell death when used in combination with therapeutics like 
cisplatin or gemcitabine by making them more sensitive to drug specific interactions.164 Its 
increased potency, which is 1000x more potent than HU,165 could be linked to a potential 
binding site at 2.166 Despite its clear clinical use and studies suggesting the active form 
during inhibition, in-depth molecular studies have not been performed to gain a clear 
picture of the method of inhibition by Triapine. Understanding the intricacies of inhibitor 
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interactions with their target enzymes will direct future drug engineering to design more 
potent therapies that can potentially mimic Triapine.  
1.3.3 AzidoUDP 
After the discovery of 3′-azido-3′-deoxythymidine (AZT) for the treatment of the 
human immunodeficiency virus (HIV),167 there was a drastic increase in the study of new 
azido compounds to develop new treatment options. An RNR inhibitor that differentiates 
itself from the radical scavengers is 2´-azido-2´-deoxyuridine-5´-diphosphate (AzUDP). 
AzUDP mimics the substrate and binds in the active site. When bound it initiates radical 
transfer but ultimately forms a moderately stable nitrogen radical and traps the radical from 
returning to Y122. EPR identified the newly formed radical species was localized to the 
substrate being reduced in the active site.85, 168 While not clinically relevant, as there is no 
direct specificity to cancerous cells, AzidoUDP aids in controlling the reaction mechanism 
behind long-range PCET to monitor previously unobservable conformational enzymatic 
states in conjunction with measuring the distances between radical initiation site in a  
subunit and the substrate turnover site in the  subunit.169  
1.4 FT-IR Spectroscopy 
1.4.1 General introduction 
Fourier-transform infrared (FT-IR) spectroscopy uses an essential piece of optical 
hardware, the interferometer, to collect high-spectral-resolution data over a wide spectral 
range.170 Infrared light is emitted by a source and is directed into the interferometer to a 
beam splitter. The beam splitter directs half of the beam to a fixed mirror over a distance 
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(L) where it reflects the beam to the beam splitter having travelled a distance of 2L. The 
other portion of the infrared beam is directed to a second mirror with no fixed position. 
This mirror is under precise direction where it is moved around L by a controlled distance 
of x. The beam is reflected back to the beam splitter having travelled a distance of 2L  x. 
Once recombined at the beam splitter, the two beams display a path length difference of 2x 
and will interfere when they recombine. The beam then exits the interferometer where it 
passes through the sample compartment and focused on the detector. This measured 
quantity is the intensity, I (x), of the combined beams as a function of the displacement of 
the mirror by distance x. The resulting interferogram is converted into a spectrum by means 
of Fourier transformation. There are 3 advantages of FT-IR spectroscopy over scanning 
spectroscopy: Fellgett’s, Jacquinot’s, and Connes’ advantage.171-173 Fellgett’s advantage 
states that it collects all waves simultaneously at a higher signal-to-noise ratio.171 
Jacquinot’s advantage (throughput advantage) states that the monochromator restricts the 
light that passes through it. This removes extraneous sources of light from entering the 
interferometer where throughput is based solely upon the diameter of the collimated beam 
from the IR source.172 Finally, there is Connes’ advantage of using a laser with a known 
wavelength passing through the interferometer. This provides a more stable and precise 
determination of vibrational modes than dispersive techniques that rely upon diffraction 
gratings.173 Covalent bonds are modelled as two masses connected by a spring of a 
particular force constant k. The basic model for a harmonic oscillator with its modification 
to account for anharmonicity is enough to determine the origin of characteristic frequencies 
that can be assigned to functional groups within a molecule. Hooke’s law expresses the 






, where  is the 
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reduced mass of the atom. The reduced mass is defined as   =  
𝑚1𝑚2
𝑚1+ 𝑚2
, in which m1 and 
m2 represent the masses of the chemical bond.174 When a polar bond vibrates, the 
oscillating dipole creates a varying electric field. The stronger the dipole moment of the 
oscillating band, the stronger the electric field. If the IR frequency matches the frequency 
of the oscillating electromagnetic (EM) field, then the light is absorbed. If they do not, then 
the light is transmitted. Position of absorbing bands are influenced by the relative size of 
the molecule. Generally speaking, atoms or proteins of lighter mass and stronger bonds 
will display higher energy oscillations. Vibrational modes can be localized over two atoms, 
but can also be a number of atom motions occurring simultaneously.175 FT-IR spectroscopy 
is used for detection of functional groups by examining the interaction of the EM spectrum 
with actual bonds and probing the functionality of a molecule. Covalent molecules have 
numerous types of bonds with roughly the same energy (C-C, C-H, C=O, etc.). These bonds 
show up in similar regions in the IR spectrum and can be categorized. With the Born 
Oppenheimer approximation of nuclei and electrons, you get a formula which describes 
the degrees of freedoms with 3 rotational degrees of freedom related to the center of mass 
motion of a molecule independent of whether the molecule is linear or nonlinear. Nonlinear 
molecules contain 3 modes of translation and 3 modes of rotation allowing for 3N-6 
degrees of freedom for a molecule with a given number of atoms, N. Linear molecules 
retain all 3 modes of translation, but the rotational mode around the line between the atoms 
does not represent a change in physical space, therefore, there are only 2 rotational modes 
and is describes as 3N-5. These models presume a polyatomic molecule of N > 2. 
Excluding the simplest of compounds, most molecules have a nonlinear structure. This 
typically implies high sets of absorption frequencies, however, a lower number of 
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vibrations are observed due to redundant or degenerate vibrational modes. Absorption 
bands increase proportionately given the frequency of appearance of a functional group in 
a molecule. 
The FT-IR spectroscopy has several comparative strengths to other methods of 
biological measurements. Nuclear magnetic resonance (NMR) spectroscopy has been  
historically limited by protein size.176 Membrane environments induce line broadening 
effects associated with motion restriction in NMR spectroscopy177 and light scattering 
artifacts in circular dichroism (CD) spectroscopy.178 FT-IR spectroscopy is not limited by 
environmental factors or the size of proteins. Amide absorbance bands were originally 
assigned using force field treatments of amide vibrational regions to assign the IR 
absorbance of protein secondary structure.179 FT-IR assignment was expanded upon to 
incorporate dihedral angles. Dihedral angles determine the overall geometry associated 
with the bonds, and it can be inferred from this information the strength and length of the 
bonds associated with the geometry of the molecule. The inclusion of this information 
influences the predicted energies of proposed protein secondary structure and can fine tune 
amide absorbance bands to more accurately predict where these bands will appear in the 
spectrum.180 Amide I frequencies (1695-1610 cm-1) have been reported as follows: anti-
parallel -sheet (1695-1675 cm-1), -helix (1660-1648 cm-1), disordered (1648-1640 cm-
1), -sheet (1640-1625 cm-1), and aggregated strands (1628-1610 cm-1).181-184 Amide II 
frequencies relating to predominantly -helical proteins are higher energy compared to 
mainly -sheet proteins having spectral ranges of 1551-1545 cm-1 and 1525-1521 cm-1, 
respectively.185-186 
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1.4.2 Difference FT-IR spectroscopy 
FT-IR spectroscopy is a powerful technique that is able to detect perturbations in 
hydrogen bonding by shifts in frequency in amide regions in as little as 0.002 Å. 187 The 
principle theory for difference spectroscopy is the subtraction of protein absorbance spectra 
collected in state A from the spectra in state B.188 Any vibrational frequency that is 
unaffected between the two states is subtracted out, simplifying the overall spectrum. 
Assignment of functional groups can still remain complex given the fluidity and scope of 
conformational changes in large proteins. Site-directed mutagenesis causes shifts in 
frequency based on reduced mass that makes the assignment of complex spectra more 
manageable.189 Heavier isotopes are able to drastically effect the vibrational frequencies. 
These techniques enable the detection of single amino acid changes in the 260 kDa RNR 
holoenzyme. In the work presented, absorbance spectra were collected for two minutes 
after which there is a six-minute incubation time between these two points to allow 
turnover or inhibition to occur followed by another two-minute collection. To assess the 
catalytic state of the active complex, inhibitor is not added to the reaction mixture. The 
experimental design in this thesis was designed to maximize catalysis and inhibition signal-
to-noise while minimizing baseline drift using UV-VIS absorbance kinetics.  
1.4.3 Site-directed mutagenesis in RNR FT-IR spectroscopy 
Difference FT-IR spectra are shown in Figure 1.10. In these difference FT-IR 
spectroscopy experiments, isolated 2 was monitored. In Figure 1.10 A, no inhibitor was 
added to the solution of 2. In a control experiment, a spectrum of 2 was measured at t1 
and t2. A difference spectrum was calculated from 2 at t1 minus 2 at t2. As is to be 
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expected, the average conformations of 2 at t1 are no different than the average 
conformations of 2 at t2, thus the difference spectrum measures no changes. However, in 
the case of Figure 1.10 B, radical scavenger HU was inoculated in the isolated 2 solution 
which quenched the tyrosyl radical.  
Previous work in our lab has consisted of global isotopic labeling experiments of 
2 residues which began with Y122.190 Isotopic labeling not only shifts absorbance bands 
associated with the incorporation of labels due to changes in mass. Among 16 tyrosines in 
2, Y122• is spectroscopically unique.191 Global labelling tyrosine in 2 using 2H4-Y 
identified spectral contributions at 1498 cm-1 and 1514 cm-1 were due to Y122• and 
Y122OH, respectively. FT-IR spectroscopy revealed a dramatic 76 cm-1 downshift of the 
negative 1514 cm-1 band to 1438 cm-1.  This band is assignable to the stretching vibration 
of the tyrosines ring. An isotope down shift of 80 cm-1 is predicted by density functional 
theory (DFT) calculations. A second peak was observed to downshift 18 cm-1 from 1498 
cm-1 to 1480 cm-1. This signal is attributable to the C-O stretching vibration of the radical 
at Y122, supported by a 20 cm-1 downshift predicted by DFT calculations. These results 
illustrated the coupling of electron transfer to and from Y122 to conformational changes 
observed in the 2 subunit.  
In agreement with these finding, small perturbations at 1661 and 1652 cm-1 were 
observed. Amide I C=O have multiple contributions from 1695-1610 cm-1 supporting the 
claim that radical reduction is associated with conformational reorientation. Furthermore, 
the connection between Y122 and D84 upon radical reduction was examined using globally 
labelled 13C- and 4-13C-aspartate 2 isotopic labeling as well as hydroxyurea and 
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hydroxylamine to induce single electron reduction.192 Upon radical reduction, the iron 
bound D84 to act as a probe for hydrogen bonding modifications at the metal cluster.  The 
positive 1687 cm-1 and the negative 1675 cm-1 bands downshifted to 1644 and 1635 cm-1, 
respectively. These shifts were in agreement with simulated data that predicted a 43 cm-1 
downshift. These labels also observed downshifts associated with 1661 and 1653 cm-1 
bands to 1621 and 1613 cm-1.192 These results not only marked that D84 was sensitive to 
electrostatic changes around the metal cofactor, but that hydrogen bonding interactions 
were altered due to radical reduction at Y122. These findings were expanded upon 
difference spectroscopy using 13C global labelling of the C1 tyrosine carbon and DFT 
calculations with Newman projects to specifically identify the chemistry surrounding the 
radical generation site. Comparison of experimental and simulated isotope-edited FT-IR 
spectroscopy identified Y122 undergoing a conformational change during radical 
reduction forming a hydrogen bond with the conserved D84 iron bound residue. 
Examination of solvent isotope effects and proton inventories agree with the findings as 
there are two rate limiting electron transfer reactions, a large isotope effect (11.9), and a 
small isotope effect (1.4). The large isotope effect is a consequence of the oxidation 
reaction of HU. The small isotope effect is believed to be due to small hydrogen bonding 
changes associated with D84 and the formation of a hydrogen bond between Y122 and 
D84 after radical reduction.193 Isotope effects of < 3 have been observed in enzymes that 
use hydrogen bonds to stabilize catalysis.194 The results of these studies have identified key 
structural bands associated with reaction-induced Fourier-transform infrared (RIFT-IR) 
spectroscopy seen in Figure 1.10, as well as elucidating the first step associated with radical 
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transfer. Each of these studies was conducted in isolated 2 and the work presented in this 
thesis expands to include the QC and allosteric regulation observed in the  subunit. 
The work presented in this thesis aims to move beyond isolated 2. To incorporate 
the  subunit and to begin to investigate the structural characteristics of the active 22 
complex. The investigation of this complex aims to better understand the conformational 
dynamics associated with the PCET pathway and gain a deeper understanding of the 
mechanism of nucleotide reduction. Furthermore, the interaction between inhibitor and the 
QC strives to determine the means of inhibition that occurs in RNR and to understand the 
interactions that lead to enzyme inactivity. 
 
Figure 1.10 Reaction-induced FT-IR difference spectra. (A) 100 µM of isolated 2 
with no inhibitors. (B) 100 µM of isolated 2 with 50 mM HU. Difference spectra were 
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CHAPTER 2. REDOX-DEPENDENT STRUCTURAL COUPLING 
BETWEEN THE 2 AND Β2 SUBUNITS IN E. COLI 
RIBONUCLEOTIDE REDUCTASE 
Reprinted with permission from Offenbacher, A. R., Watson, R. A., Pagba, C. V., Barry, 
B. A. Redox-dependent structural coupling between the α2 and β2 subunits in E. coli 
ribonucleotide reductase. The Journal of Physical Chemistry B 2014, 118, 2993-3004. 
Copyright 2018 American Chemical Society. 
2.1 Abstract 
Ribonucleotide reductase (RNR) catalyzes the production of deoxyribonucleotides 
in all cells.  In E. coli class Ia RNR, a transient 2β2 complex forms when a ribonucleotide 
substrate, such as CDP, binds to the 2 subunit.  A tyrosyl radical (Y122O•)-diferric 
cofactor in β2 initiates substrate reduction in 2 via a long distance, proton-coupled 
electron transfer (PCET) process.  Here, we use reaction-induced FT-IR spectroscopy to 
describe the 2β2 structural landscapes, which are associated with dATP and hydroxyurea 
(HU) inhibition.  Spectra were acquired after mixing E. coli 2 and β2 with a substrate, 
CDP, and the allosteric effector, ATP.  Isotopic chimeras, 13C2β2 and 213Cβ2, were 
used to define subunit-specific structural changes.  Mixing of 2 and β2 under turnover 
conditions yielded amide I (C=O) and II (CN/NH) bands, derived from each subunit.  The 
addition of the inhibitor, dATP, resulted in a decreased contribution from amide I bands, 
attributable to beta strands and disordered structures.  Significantly, HU-mediated 
reduction of Y122O• was associated with structural changes in 2, as well as β2.  To define 
the spectral contributions of Y122O•/Y122OH in the quaternary complex, 2H4 labeling of 
β2 tyrosines and HU-editing were performed.  The bands of Y122O•, Y122OH, and D84, 
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a unidentate ligand to the diferric cluster, previously identified in isolated β2, were 
observed in the 2β2 complex.  These spectra also provide evidence for a conformational 
rearrangement at an additional β2 tyrosine(s), Yx, in the 2β2/CDP/ATP complex.  This 
study illustrates the utility of reaction-induced FT-IR spectroscopy in the study of complex 
enzymes. 
2.2 Introduction 
A critical barrier in the development of new anti-cancer and anti-viral pharmaceuticals is 
an understanding of drug interactions with complex enzyme targets in solution.  
Ribonucleotide reductase (RNR) is a complex, multi-subunit enzyme that provides 
deoxynucleotides, the essential building blocks for DNA biosynthesis and repair in all 
organisms.1  Therefore, RNR plays a pivotal role in nucleic acid metabolism and cell 
division and is a target for anti-cancer and anti-viral therapies (reviewed in 2-3).  Clinically 
relevant, chemotherapeutic agents, suppress the activity of RNR.4  This inhibition impedes 
DNA replication and triggers tumor-cell death.  In this paper, we use a new technique to 
provide detailed information about the interactions of one of these therapeutic agents with 
RNR. 
 In all RNRs, the reduction of ribonucleotides to deoxyribonucleotides proceeds 
through a free radical mechanism (reviewed in 2, 5). The reaction is initiated by H atom 
abstraction at the ribose 3′-carbon using an active site, transient cysteine radical.6-7 There 
are three classes of RNRs that are classified according to the cofactors used to generate the 
active site cysteine.2, 8-9 Class Ia RNRs, found in mammals and bacteria, are composed of 
2 and β2 subunits, and use a tyrosyl radical (Y122O•)-diferric cofactor to generate the 
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thiyl radical (see Figure 2.1). The prototype of the class Ia enzyme is derived from 
Escherichia coli. The binding and reduction of substrate occurs in the 2 subunit (Figure 
2.1A). In addition, class Ia 2 contains two effector sites, one termed the specificity site 
and the other termed the overall activity site.  ATP stimulates nucleotide reduction, while 
dATP is a reversible inhibitor that binds at the activity site.10 In E. coli, dATP promotes 
formation of inactive, ring-like, 4β4 oligomers in which the β2 subunit is rotated away 
from its normal docking position.11-13  The effectors, ATP and dATP, also bind to the 
specificity site and promote CDP reduction.14   Binding of effectors, such as dATP, dTTP, 
and dGTP, stimulate interactions between 2 and β2.11-13 
 A tyrosyl radical,15 Y122O•, located in the β2 subunit,16-17 oxidizes the active site 
cysteine, C439, to initiate substrate reduction in the 2 subunit.6, 18 This tyrosyl radical is 
generated by oxygen-requiring redox reactions at a diiron cluster and is required for 
activity.19-21 Binding of substrate, such as CDP, and an effector, such as ATP, to 2 
promotes the transient formation of the functional (2)nβ2 (n = 1 or 3) quaternary 
complex.11-12, 22 A docking model, small angle X-ray scattering, and electron microscopy 
11-12, 22-23 support the conclusion that radical  propagation between Y122 and C439 occurs 
over 35 Å (see Figure 2.1A-C). This distance has also been substantiated by pulsed 
electron-electron double resonance spectroscopy.24-25  
 The transient thiyl radical, in the 170kDa 2 subunit, is generated from Y122O• by 
a reversible, multi-step proton coupled electron transfer (PCET) process, involving a 
conserved pathway (β2: Y122O• ⇋ [W48] ⇋ Y356 ⇋ 2: Y731 ⇋ Y730 ⇋ C439).26 The 
role of these residues was suggested by site-directed mutagenesis27-29 and the radical 
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transfer mechanism has been elucidated using site-specific incorporation of unnatural 
amino acids.30-35 In the E. coli quaternary complex, the redox chemistry of Y122O• is rapid, 
but is gated by a conformational step.36  
 
Figure 2.1 (A) Active site residues in the 2 subunit at 3.2 Å (PDB 4R1R) and 
containing the substrate, GDP.37 (B) Y122OH-differric cluster in β2 at 1.9 Å (PDB 
1MXR).38 The solid line is the distance, as determined from the 2β2 docking model23 
and PELDOR25 measurements, between β2 Y122 and 2 C439, which initiates 
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substrate reduction. The proposed conformational change at Y122O• in the isolated 
β2 subunit is superimposed in (B) in yellow, and is modeled in a YT dipeptide, as an 
A (backbone/ring dihedral angles: 173°/99°) to B (-69°/80°) conformational change.38-
39 Iron atoms are shown as orange spheres. (C) highlights the secondary structure of 
2 (PDB 4R1R) and β2 (PDB 1MXR) subunits. The secondary structure elements are 
color-coded (2: helix, salmon, beta, red, disordered, yellow and β2: helix, blue, beta, 
cyan, disordered, green). The substrates (GDP) and effectors (TTP) in 2 are 
represented as marine and lime spheres, respectively, the iron atoms in β2 are 
represented as black spheres. Loop 2 is highlighted in black and annotated. Note that 
(C) is presented to depict secondary structure and is not a docking model (see refs23, 
26). 
 A complete description of this conformational gate is still not available. Currently, 
there is no high-resolution crystal structure of the class Ia 2β2 holoenzyme nor is there a 
structure of the isolated differic-Y122O• β2 subunit.  Recent work has implicated an iron-
bound water as the initial proton donor.40-41 Therefore, the conformational gate could be 
linked to the proton transfer to Y122O•.42  In the 1.4 Å structure of the diferric-Y122OH 
state (Met-β2), Y122OH is within hydrogen bonding distance (3.4 Å) of D84, a ligand of 
the diiron cluster (Figure 1B).38 However, the radical state (Y122O•) is not hydrogen 
bonded.43-44 Electron paramagnetic resonance (EPR)38 and vibrational spectroscopic 
studies of isolated β239, 45 suggest that the phenoxyl ring translates away from D84 (Figure 
1B, yellow), when Y122O• is oxidized.  In isolated β2, this displacement has been shown 
to alter hydrogen bonding at D84.46 
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 Reaction-induced FT-IR spectroscopy is a high-resolution technique, which can 
detect changes in protein structure in real time and with residue-specific resolution.47-49 For 
RNR, this technique has been used to study reactions in the isolated β2 subunit,39, 46, 50 but 
has not yet been used to study the 2β2 complex.  Here, we use reaction-induced FT-IR 
vibrational spectroscopy to describe the conformational landscape of RNR under catalytic 
and inhibited conditions.  
2.3 Materials and Methods 
2.3.1 Materials.  
HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, sodium hydroxide, 
and hydrochloric acid were purchased from Sigma (St. Louis, MO). Sodium deuteroxide 
(NaOD, 99.5%), deuterium oxide (D2O, 98%), U-13C-glucose (99%), and L-2H4-tyrosine 
(2Hring-tyrosine, 98%) were obtained from Cambridge Isotope Laboratories (Andover, 
MA). Hydroxyurea (HU) was purchased from Calbiochem (San Diego, CA). 
2.3.2 Expression and purification of the E. coli 2 and β2 subunits of RNR.  
Natural abundance, N-terminal His6-tagged  (2) was overexpressed using 
BL21(DE3) Star cells and purified by a Ni-NTA column, as described previously.34 Natural 
abundance, wild-type β (β2) was overexpressed using BL21(DE3) cells and purified, as 
described previously.51 Protein purity was assessed by SDS-PAGE (see Figure S1). Global 
13C labeling of all β2 carbons (13C-β2) was conducted as described in ref39, 52, global 13C 
labeling of all 2 carbons (13C-2) was prepared by the same protocol. With this protocol, 
the extent of 13C labeling has been quantified at > 90% using mass spec analysis.52 Specific 
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2H4-tyrosine labeling of all β2 tyrosines (2H4Y-β2, 16 tyrosines per β monomer) was 
performed as described previously.50 With this protocol, the extent of 2H4 labeling at all β2 
tyrosines has been quantified at 90% using mass spec analysis.31 Average yields of 2 and 
13C2 were 60 and 56 mg per g of cell paste, respectively. Average yields of β2, 13Cβ2, 
and 2H4Yβ2 were 22, 15, and 5 mg per g of cell paste, respectively. The  and β homodimer 
concentrations were determined using UV-visible spectroscopy and the extinction 
coefficients, ɛ280 = 189 mM-1cm-1 for 253 and ɛ280 = 131 mM-1cm-1 for β2.19  The tyrosyl 
radical (Y122O•) content in β2 (per homodimer) was determined spectrophotometrically 
by the drop-line method54 and the average values for β2, 13Cβ2, and 2H4Yβ2 were 1.1, 1.0, 
and 0.9, respectively.  The purities of the natural abundance and isotopically labeled 
samples was also assessed by Coomassie-stained SDS-PAGE50 and were found to be 
similar (Figure S1). RNR activities were determined using the spectrophotometric assay, 
which monitors NADPH consumption in the coupled assay containing thioredoxin (TR) 
and thioredoxin reductase (TRR).36 The assays were carried out at room temperature and 
contained 0.1 μM α2, 0.5 μM β2, 30 μM TR, 0.5 μM TRR, 0.2 mM NADPH, 3 mM ATP, 
1.0 mM CDP, 15 mM MgSO4, and 1 mM EDTA in 50 mM HEPES, pH 7.6. The buffer 
was mixed with MgSO4, EDTA, DTT, ATP and CDP, then α2, TR, TRR and NADPH 
were added. The reaction was then initiated by the addition of β2 and by monitoring the 
absorbance at 340 nm. Typical 2 activity rates were 2000-2300 nmol (min×mg)-1, 
consistent with previous reports.34, 36 Prior to UV-Vis kinetic or Fourier transform infrared 
(FT-IR) experiments, 2 and β2 samples were separately exchanged50 using Ultracel-30 
membrane into 5mM HEPES, pD 7.6 (pD values are reported without correction, see refs55-
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56). The buffer for the 2 samples also contained 5mM dithiothreitol (DTT) to maintain 
reduced 2.   
2.3.3 Reaction-Induced FT-IR Spectroscopy.  
Reaction-induced FT-IR spectra were collected at 20°C on a Nicolet Magna 550 II 
spectrometer, equipped with a MCT-A detector (Nicolet, Madison, WI). The protein 
samples were prepared at 300 µL volumes containing (final concentrations): 100 µM 2 
(when present), 100 µM β2, 3 mM CDP, 1 mM ATP (or 1 mM dATP), 5 mM DTT, 15 
mM MgSO4, and 1 mM EDTA in 5 mM HEPES (pD 7.6). The reactions were prepared as 
described for the UV-Vis kinetic measurements below. HU, when applicable, was added 
immediately and last to a final concentration of 50 mM. The reaction was injected into a 
temperature-controlled CaF2 flow cell, using a syringe pump (see refs46, 50 for details). The 
path length used for these experiments was 50 microns. 120 s of data (4 cm-1 resolution, 
595 interferograms, and 2.53 cm s-1 mirror velocity) were acquired, followed by a 360 s 
incubation, and then a second 120 s data acquisition was conducted. All data were 
processed using a Happ-Genzel apodization function, two levels of zero filling, and a Mertz 
phase correction. Each single beam set was ratioed to an open beam background, which 
consisted of the CaF2 windows of the flow cell without buffer or sample and converted to 
absorption spectra. Individual absorption spectra (see Figure 2) were then subtracted to 
generate a difference spectrum (Scheme 2.1, part I).  Absorption spectra of the reagents, 
CDP, HU, and ATP were recorded using the same conditions. FT-IR difference spectra 
(for example, see Figure 2.3A) were generated as before-minus-after the 360 s incubation. 
This time regime was chosen to maximize Y122O• reduction in the presence of HU, while 
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minimizing spectral artifacts from baseline drifts. For the HU reactions, these difference 
spectra reflect “Y122O•”-minus-“Y122OH” (Scheme 2.2, part I) and 50% reduction of 
Y122O•.50  The data were reproducible, as shown in Figure S2.  Isotope-edited spectra 
(Scheme 2.1, parts II and IV) were generated as NA-minus-isotope, prior to subtraction, 
the difference spectra were normalized for the Y122O• content (per β2 homodimer, for 
example, see ref 39).  
 
Figure 2.2 FT-IR absorption spectra.  Samples were (A) 2β2 (solid red), 13C2-β2 
(dashed red), 2-13Cβ2 (dashed blue), 2-2H4Yβ2 (solid blue), and β2 (black).  The 
samples were prepared at 100 µM 2 (when present) and 100 µM β2 in 5 mM HEPES 
(pD 7.6) buffer, supplemented with 3 mM CDP, 1 mM ATP, 5 mM DTT, 15 mM 
MgSO4, and 1 mM EDTA. Isotope-edited spectra (B-D) represent (B) 2β2-minus-
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13C2-β2, (C) 2β2-minus-2-13Cβ2, and (D) 2β2-minus-2-2H4Yβ2. To generate 
the dashed line in (D) the solid line was multiplied by a factor of 5 and is presented 
for comparison. The spectra are offset along the y-axis for comparison. Tick marks: 
2 × 10-1 absorbance units. Averages: (A) 10 (solid red), 9 (solid blue), 10 (dashed red), 
4 (dashed blue), and 8 (black) separate samples. The temperature was 20°C. 
2.3.4 UV-Vis Kinetic Analysis of Y122O•.  
The kinetic reactions (Figure S3) were performed at 20°C with a Varian Cary 50 
(Varian, Walnut Creek, CA) spectrophotometer. The reactions contained (300 µL final 
volume) 35 µM 2, 35 µM β2, 3 mM CDP, 1 mM ATP, 5 mM DTT, 15 mM MgSO4, and 
1 mM EDTA in 5 mM HEPES (pD 7.6) buffer. The samples were prepared from 
concentrated stocks and added to buffer in the following order: DTT, MgSO4/EDTA, ATP, 
CDP, and 2. β2 was subsequently added to initiate substrate reduction. Hydroxyurea was 
added immediately and last (50 mM final concentration) to reduce Y122O• in the 
experiments (see Figure S3A, B and D). In the absence of HU, no change in Y122O• was 
observed during the steady-state reactions over the 30 min time scans (Figure S3C). For 
each of the reactions, second-order HU rate constants were extracted from 
monoexponential fits to the % Y122O•, plotted at each time point (see insets in Figures 







.54 The data in Figure S3 represent 3-4 averages 
for each decay fit.  No corrections or normalizations were applied to the UV spectra before 
this data analysis.  The values derived from this analysis were reproducible, as judged from 
the standard deviation (see error bars in Figure S3).  For reactions containing dATP (Figure 
S3D), 1 mM dATP was added instead of 1 mM ATP.  
Scheme 2.1 Methods used to generate reaction-induced FT-IR spectra.a    
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aIn (I), the typical regions of carboxylate (COO–) and amide (pink, amide I (C=O), 
blue, amide II (CN/NH, inaccessible to H/D exchange), and green, amide II′ (CN, 
accessible to H/D exchange)) vibrational modes are labeled. Time points, t1 and t2, 
represent data collected immediately (t1) following rapid mixing and six minutes (t2) 
after t1.  
2.4 Results 
2.4.1 Isotope shifts derived from the FT-IR absorption spectrum of 2β2.    
Figure 2.2A (solid red) displays the 1850-1350 cm-1 region of the FT-IR absorption 
spectra, recorded from the quaternary complex (QC), 2β2/CDP/ATP, under turnover 
conditions. This region is dominated by amide I, II, and III and carboxylate vibrations (see 
color coding in Scheme 2.1, part I). The frequency of the amide I (C=O) vibration (1690-
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1620 cm-1) is sensitive to changes in secondary structure (-helix: 1660-1650, parallel and 
antiparallel β-sheet: 1690/1620, loop/unstructured: 1640 cm-1) and in hydrogen bonding.57-
62 All protein samples were exchanged into D2O buffer to downshift the water HOH 
bending (1640 cm-1) band from the protein amide I region. Exchange of protein amide 
groups with deuterium is expected to shift the CN contribution of the amide II mode to 
~1450 cm-1 and the NH contribution to ~1000 cm-1. D2O exhibits an intense vibrational 
band at 1200 cm-1, thus preventing analysis below ~ 1300 cm-1.  To identify bands arising 
from 2 and β2 in the experiments, described below, the subunits were individually global-
labeled with 13C. The biosynthetic isotope enrichment approach has been shown to give 
>90% labeling.52 The FT-IR absorption spectra of isotopic chimeras, in which one subunit 
is labeled and one subunit is globally labeled, are shown in Figure 2.2 B and C.  A 46 cm-
1 downshift of an amide I band component was observed in the isotopic chimera in which 
2 was 13C labeled and in which β2 was natural abundance (13C2β2, Figure 2.2 B).  A 46 
cm-1 downshift was also observed in the isotopic chimera in which β2 was 13C labeled and 
2 was natural abundance (213Cβ2, Figure 2.2 C).    
2.4.2 Preparations employed.   
Scheme 2.2 introduces the preparations employed in reaction-induced FT-IR 
experiments.  In Scheme 2.2, part 1, isolated β2 is treated with HU, which quenches the 
Y122 radical.  In Scheme 2.2, part II, 2, β2, CDP, and ATP are mixed, in the presence of 
reductant, to generate the QC.  In Scheme 2.2, part III, 2, β2, CDP, and dATP are mixed, 
this sample is inactive.  Binding of dATP to the overall activity site prevents turnover and 
has been reported to promote oligomerization, generating an inactive 4β4 complex in E. 
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coli.11-12  dATP also binds at the specificity site.  In the presence of dATP, CDP may bind 
to reduced 2.13-14, 37  In Scheme 2.2, part IV, HU is added to the QC, which is inactivated 
by this treatment.  HU quenches the tyrosyl radical in a PCET process.39, 63  In the 
quaternary complex, the HU reaction occurs with an accelerated rate, compared to isolated 
β2.64  However, in D2O, the reaction of HU with the quaternary complex is not accelerated, 
but occurs with the same rate as in isolated β2 (Figure S3 A and B). 
Scheme 2.2 Preparations containing 2 and β2 subunits of E. coli RNR. 
 
   
2.4.3 Methods used to construct reaction-induced FT-IR spectra.   
Scheme 1 illustrates the method used to generate reaction-induced spectra.  Starting 
with absorption spectra (such as the example in Figure 2.2), difference spectra were 
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constructed (Scheme 2.1, part 1).  Spectra were acquired immediately following mixing, 
corresponding to a 2 min (t1) time point.  After 6 minutes, a second 2 min spectrum was 
acquired, corresponding to time point t2.  The t1-minus-t2 reflects the generation of the QC 
in samples that contain 2, β2, CDP, and ATP.  At the t2 time point, the reaction is 
complete, and the transient QC will not persist.  On this timescale, all the available CDP 
substrate is predicted to be consumed. Thus, this spectrum reflects structural changes 
induced by formation of the QC and turnover.  In HU-containing samples, the reaction-
induced spectrum reflects structural changes induced by quenching of the β2 tyrosyl radical 
in the QC.  This time frame was chosen to maximize signal while avoiding baseline drift.  
Reaction-induced FT-IR spectra were HU-edited by subtraction, HU treated-minus-no HU 
(Scheme 2.1, part III). Reaction-induced FT-IR spectra were isotope-edited by subtraction, 
natural abundance-minus-isotopically labeled (Scheme 2.1, part II).  Isotopically labeled 
samples included globally 13C labeled 2, globally 13C labeled β2, and 2H4Y-labeled β2.   
2.4.4 Reaction-induced FT-IR spectra associated with mixing 2β2/CDP/ATP to form 
the QC.   
Figure 2.3 A presents the reaction-induced FT-IR spectra of the QC (Scheme 2.1, 
part I).  Complex spectral signatures were observed in the spectrum obtained from mixing 
DTT, 2, β2, ATP, and CDP (Figure 2.3 A).  Note that mixing data recorded from a β2 
control (Figure 2.3 F), containing no 2, but the same buffer and components as A, gave a 
flat baseline.  In Figure 2.3 A, prominent bands in amide I (CO 1650 cm-1) and amide II 
(CN/NH, 1550 cm-1) regions reflect alterations in secondary structure and hydrogen 
bonding.61  The appearance of these bands is attributable to formation of protein-protein 
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contacts and turnover-associated conformational alterations in the 2β2 complex.  The 
observation of amide II bands at 1550 cm-1 is potentially significant, because solvent-
exposed regions of proteins into D2O are observed at 1450 cm-1 (amide II′).  The 
asymmetric stretching vibration of carboxylate side chains may also contribute in this 
region.65   Bands in the 1425-1400 cm-1 region are assignable to the corresponding, 
symmetric carboxylate side chain vibrational bands.65   
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Figure 2.3 Reaction-induced FT-IR spectra of the 2β2 quaternary complex under 
turnover and dATP-inhibited conditions (Scheme 1, part 1). Samples were (A) 
2β2/CDP/ATP, (B) 13C2-β2/CDP/ATP, (C) 2-13Cβ2/CDP/ATP, (D) 2-
2H4Yβ2/CDP/ATP, and (E) the dATP-inhibited complex, 2β2/CDP/dATP.  The 
spectrum in (F) was acquired from isolated β2 under the conditions used in (A).  The 
samples were prepared at 100µM 2 (when present), 100µM β2 in 5mM HEPES (pD 
7.6) buffer, supplemented with 3mM CDP, 1mM ATP (or dATP), 5mM DTT, 15mM 
MgSO4, and 1mM EDTA. The spectra were offset along the y-axis for comparison. 
Tick marks: 1 × 10-3 absorbance units. Averages: (A) 10, (B) 10, (C) 4, (D) 9, (E) 10, 
and (F) 3 separate samples.  The temperature was 20oC. 
2.4.5 Reaction-induced FT-IR spectra of globally 13C labelled isotopic chimeras. 
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Reaction-induced FT-IR difference spectra were collected for the isotopic 
chimeras, 13C2β2 (Figure 3 B) and 213Cβ2 (Figure 2.3 C), assembled into the QC.   In 
Figure 2.3 B and C, spectral downshifts of amide I (~1650 cm-1) and II (~1550 cm-1) bands 
are apparent (Table 1).  Isotope-sensitive amide I bands are consistent with a change in 2 
and β2 structure following mixing.  Moreover, as assessed from the isotope-edited spectra 
(see Figure S4 and Scheme 2.1, part II), the conformational changes arising in the two 
subunits are distinct.  From the isotope shifts, bands at 1691, 1681, 1672 and 1622 cm-1 are 
assignable to 2 (Table 2.1).  Bands at 1661 and 1643 have a contribution both from 2 
and β2.  Note that 13C labeling of β2 causes small frequency shifts in the 2 bands in the 
1691-1672 cm-1 region (Figures 2.3 C and S4B), as expected due to alterations in transition 
dipole coupling.59 However, the pattern of intensities and frequencies is similar.  Based on 
characteristic spectral regions, the 1643 cm-1 bands are assigned to disordered structure and 
the 1681-1622 cm-1 bands are assigned primarily to beta strands.57, 60, 62, 66  Note that there 
may be overlap among these characteristic ranges.60   The 1691 cm-1 band may arise either 
from a beta strand or from an amino acid side chain, such as asparagine or glutamine.62, 67  
Amide II and asymmetric carboxylate bands, derived from 2, are also observed in the 
1550 cm-1 region of Figure 2.3 A.  Symmetric carboxylate bands at 1425, 1414, and 1400 
cm-1 are assigned to 2 (Table 2.1).  The β2 subunit has an overlapping carboxylate 
contribution at 1425 and 1414 cm-1 (Figure 2.3C and Figure S4B). 
Table 2.1 Assignment of amide I and carboxylate bands based on isotopic labeling 
and reaction-induced FT-IR spectroscopy, acquired in D2O buffers. 
υ (cm-1) 
Isotope-shifted υ Subunit Assignment dATP sensitive? 
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Amide I bands identified by 2β2 mixing under turnover conditions  
(Figures 3 and S4) 
(+) 1691  1653 (13C)  
(predictedb 
1645)  
2 beta sheet or 
side chain 
No 
(–) 1681 N.D.a   
(predictedb 
1635)  
2 beta sheet Yes 
(+) 1672 1622 (13C)  
(predictedb 
1626) 
2  beta sheet Yes 
(+) 1661 N.D. 
(predictedb 
1615) 
2 and β2 beta sheet or 
alpha helix 
No 
(–) 1643 1607 
(predictedb 
1597)  
2 and β2 disordered Yes 
(–) 1622 1584 (13C) 
(predictedb 
1576) 
2 beta sheet No 
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Carboxylate side chain bands identified by 2β2 mixing under turnover conditions 
(Figures 3 and S4) 
(+) 1425 N.D. 2 and β2 asp/glu Yes 
(–) 1414 N.D. 2 and β2 asp/glu Yes 
(+) 1400 N.D. 2 asp/glu Yes 
 
Amide I bands, identified by HU reduction, either in 2β2 or in isolated β2 
(Figures 4 and 5) 
(+) 1685/7 N.O.c 2 
1644 (13C β2)d 
2 and β2  beta sheet 2  
D84 β2  
No 
(–) 1675 N.O. 2 
1635 (13C β2)d 
2 and β2 beta sheet 2  
D84 β2  
No 
(–) 1661 N.O. 2 
1621 (13C)d 
β2  D84/Y122 
amide C=O 
No 
(+) 1653 1613 (13C)d β2  D84/Y122 
amide C=O 
No 
aN.D. Not determined,  
bPredicted based on average 46 cm-1 13C isotope shift (Figure 2.2),  
cN.O. Not observed due to overlap with 13C ,  
dIsotope-shifted bands identified by specific Y and D 2 labeling in refs.39, 46, 50 
2.4.6 Reaction-induced FT-IR spectra associated with dATP inhibition.   
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Figure 3 E presents a control (Scheme 2.2, part III), in which dATP was substituted 
for ATP.   In the reaction-induced FT-IR spectrum, mixing 2 and β2 in the presence of 
dATP, CDP, and DTT altered the spectrum, compared to the ATP-containing sample 
(compare Figure 2.3 E to 2.3 A).  The ATP-dependent bands were the 1681 and 1671 cm-
1 bands of 2 and the 1643 cm-1 amide bands of 2 and β2 (Table 2.1).  The intensities of 
the symmetric carboxylate bands of 2 and β2 were also ATP sensitive.  The other 2 and 
β2 bands (Table 2.1) were observed both in the presence of dATP and in the presence of 
ATP.  These spectral bands reflect secondary structural changes induced either by dATP 
or CDP binding.   
2.4.7 Reaction-induced FT-IR spectra of the 2H4-tyrosine labeled β2 chimera.   
A third isotopic chimera was employed, in which β2 tyrosines were 2H4 labeled and 
2 was natural abundance (Figure 2.3 D).  This labeling procedure has been described 
previously,50 and results in 90% isotope enrichment of all tyrosine side chains (16 tyrosine 
residues per β monomer, including Y122O•).  Interestingly, while there was no significant 
decrease in Y122O• content during turnover, as assessed by UV-Vis kinetics (Figure S3C), 
2H4 labeling of β2 significantly altered the reaction-induced FT-IR spectrum (Figure 2.3 
D).  In the isotope-edited spectrum (Figure S4C), bands 1521, 1501, 1455 and 1414 cm-1 
are assignable to the natural abundance (1521 and 1501 cm-1) and 2H4Y labeled (1455, 
1414 cm-1) Y19a bands of a tyrosine in two different environments (Table 2.2).  An ~80 
cm-1 Y19a isotope shift is predicted by DFT calculations and model compound studies for 
2H4Y labeling.39, 68  Isotope-sensitive amide I (CO) bands were also detected in Figure S4C.   
These isotope-sensitive bands provide evidence for a conformationally active tyrosine, 
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termed Yx, in the β2 subunit, which is distinct from Y122 (see also discussion of the HU-
edited spectrum, below).  
Table 2.2 Assignment of Y122O•, Y122OH, and Yx spectral bands based on isotopic 
labeling and reaction-induced FT-IR spectroscopy, acquired in D2O buffers. 
υ (cm-1) 
Isotope-shifted υ Subunit Assignment 
 
Y122OH/Y122O• bands, identified by HU reduction in 2β2 and in isolated β2  
(Figure 6) 
(–) 1514 1436 (2H4Y)a β2 (Y19a) ring Y122OH 
(+) 1498 1480 (2H4Y)a β2 (Y7a) CO Y122• 
 
Yx bands, identified by 2β2 mixing under turnover conditions  
or by reduction of the QC with  HU (Figure 6) 
(–) 1521 1414 (2H4Y) β2 (Y19a) Yx  
(+) 1501 1455/1436 (2H4Y) β2 (Y19a) Yx  
aIsotope-shifted bands also identified in refs.39, 46, 50 
Quantitation of Yx in the 2H4-tyrosine edited spectrum.  The peaks of the 1680-1630 
cm-1 region in the isotope-edited spectrum (Figure 2.3 D), which are attributed to Yx, were 
integrated and compared to that of the 2H4Y-edited absorption spectrum, which reflects the 
isotope shifts of all 16 β2 tyrosines (Figure 2.2 D).  This analysis estimates that ~2 tyrosines 
in the β2 homodimer contribute to Figure 2.3 D.  Therefore, we attribute these bands to 













2.4.8 HU-editing of the reaction-induced FT-IR spectra.  
To define Y122O• redox-linked changes in the 2β2 complex, HU editing was 
employed (Scheme 2.1, part III).  As shown in Figure 2.4 A, HU addition to the QC altered 
the mixing spectrum and led to a well-defined HU-edited spectrum, which is associated 
with quenching of the tyrosyl radical in the QC (see Scheme 2.2, part IV).   
Figure 2.4 HU-edited, reaction-induced FT-IR spectra (HU-minus-no HU, Scheme 1, 
part III).  Samples were (A) 2β2/CDP/ATP, (B) the dATP-inhibited complex, 
2β2/CDP/dATP, and (C) isolated β2 under the conditions used in (A).  Tick marks: 
1 × 10-3 absorbance units. Averages: (A) 19, (B) 21, and (C) 8 separate samples.  The 
temperature was 20oC.  
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The HU-edited spectrum, acquired from a sample containing dATP, was found to 
be distinct (Figure 2.4 B), compared to the one acquired in the presence of ATP (Figure 
2.4 A).  An overall decrease in intensity was observed, consistent with the decreased rate 
of HU-mediated Y122O• reduction in the presence of dATP (Figure S3 A and D).  Also, 
Figure 2.4 A and B were distinguishable from the HU-edited spectrum acquired from 
isolated β2 (Figure 2.4 C and Scheme 2.2, part I) under the same conditions as A.  In Figure 
2.4A, positive bands at 1643 and 1614 cm-1 may be attributable to the consumption of the 
substrate, CDP, which occurs in the ATP-containing sample, but does not occur in the 
dATP-containing control.  Comparison to the spectrum of CDP in solution (Figure S5) 
shows that solution CDP does have overlapping contributions in this region.  However, the 
frequencies are shifted and narrow, when compared to the solution spectrum, as expected 
if CDP is bound at the substrate binding site.  These results are consistent with the 
expectation that CDP oxidation is redox-linked with Y122O•.26  However, an amide I 
contribution in this region cannot be completely excluded. 
2.4.9 HU-editing and isotopic labelling, amide bands.  
The assignment of bands in the HU-edited spectrum was investigated by isotopic 
labeling (Figure S6).  Global 13C labeling of 2 (Figure 2.5 B) downshifted (expected =46 
cm-1) a component of the 1685/1675 cm-1 bands (Figure 2.5 A, repeated from Figure 2.4 A) 
in the HU-edited spectrum.  Global 13C labeling of β2 also shifted vibrational bands, 
including the 1687, 1675, 1661, and 1653 cm-1 bands previously assigned to redox-linked 
changes at Y122 (amide) and D84 (asymmetric stretch, amide) in β2 (Figure 2.5 C).  This 
result demonstrates that the effect of HU on Y122 and D84 structure is similar in the QC 
 71 
and the isolated β2.39, 46, 50 However, in the QC, HU reduction leads to secondary structural 
changes in 2.  These HU-mediated structural changes are not dATP sensitive (Table 2.1). 
 
2.4.10 HU-editing and isotopic labelling, tyrosine and tyrosyl radical bands.   
To identify the β2 bands due to tyrosine in the HU-edited spectrum, HU-editing 
experiments were conducted on the 2H4Yβ2 isotopic chimera (Figure 2.5 D).  In this 
Figure 2.5 HU-edited, reaction-induced FT-IR spectra (HU-minus-no HU, Scheme 1, 
part III). Samples were (A) 2β2/CDP/ATP, (B) 13C2-β2/CDP/ATP, (C) 2-
13Cβ2/CDP/ATP, and (D) 2-2H4Tyrβ2/CDP/ATP. (E) is a control double difference 
spectrum, generated by subtraction of ½ of the data in Figure 3 A from the other ½ 
and division by √2.  Tick marks: 1 × 10-3 absorbance units. Averages: (A) 19, (B) 21, 
(C) 11, (D) 19, and (E) 10 separate samples.  The temperature was 20oC. 
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spectrum, spectral changes are evident, which are accentuated by construction of an 
isotope-edited spectrum (Figure 2.6 A and Scheme 2.1, part IV).  To appear in this 
spectrum, bands must be sensitive to incorporation of the isotopic label and reduction with 
HU.  In  22H4Yβ2/CDP/ATP (Figure 2.6 A), bands at (–) 1514 and (+) 1498 cm-1 were 
observed, similar to those observed in isolated β2 under the same conditions (Figure 2.6 B 
and Table 2.2).  The isotope-shifted bands were observed at (+) 1436 and (–) 1480 cm-1 in 
isolated β2 (Figure 2.6 B). Previously, these bands have been assigned to the CO stretch 
(Y7a) of Y122O• and the ring stretch (Y19a) of Y122OH in the β2 subunit, based on DFT 
calculations and isotopic labeling.39, 50  This result shows that the local environments of 
Y122O• and Y122OH are similar in isolated β2 and in the QC.  
However, when Figure 2.6 A (QC) and Figure 2.6 B (isolated β2) were compared, 
the isotope-edited/HU edited spectra were distinct in the amide I region.  We hypothesized 
that Figure 2.6 A reflects oxidation/reduction of Y122 and also a contribution from the β2 
tyrosine, Yx. To test this hypothesis, the Y122 contributions, measured in isolated β2 
(Figure 2.6 B), were subtracted from the spectrum of the QC (Figure 2.6 A).  This 
procedure generates Figure 2.6 C.  The FT-IR spectra in Figure 2.6 A and B were 
normalized for Y122O• content, and the rate of Y122O• reduction was measured to be 
similar in the QC and in isolated β2 (Figure S3, D2O buffers).  Therefore, the Y122O• and 
Y122OH contributions are expected to subtract out in Figure 2.6 C.   However, Figure 2.6 
C still exhibits 2H4Y isotope-sensitive bands at (–) 1521, (+) 1501, (–) 1455/1436, and (+) 
1414 cm-1, assignable to natural abundance and 2H4 labeled Yx (Table 2.2).   The 1501 cm-
1 Y19a band is distinguishable from Y122• Y7a (CO) at 1498 cm-1, because the ring 
stretching vibration, Y19a, is expected to exhibit a larger isotope-shift (Table 2.2).39, 50   
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Note that a similar set of bands, at 1521, 1501, 1455, and 1414 cm-1, were also assigned to 
Yx, based on mixing experiments (Figure S4C).  In the mixing experiments, there was no 
detectable decay of Y122• over the time course of these experiments (Figure S3).  Taken 
together, these data provide evidence that a second β2 tyrosine, Yx, is conformationally 
active in the QC. 
 
2.5 Discussion 
Figure 2.6 (A) Isotope-edited and HU-edited spectra of the isotopic chimera, 2-
2H4Tyrβ2/CDP/ATP (Scheme 1, part IV).  For comparison, the isotope-edited and HU-
edited spectrum of isolated 2H4Tyrβ2, under the conditions used in (A), is shown in (B).  
Data were derived from Figure 5 and S6, respectively, the conditions are described in 
those legends.  The spectrum in (C) is the subtraction of the spectrum (A)-minus-(B). 
Tick marks: 5 × 10-4 absorbance units. 
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2.5.1 Summary.   
In biological systems, PCET processes can be gated by conformational changes.69 
Ribonucleotide reductase is an excellent model, in which conformational gating regulates 
the catalytic PCET events.26, 36, 42 Also, RNR is subject to complex allosteric regulation, 
which is still not completely understood.  There are relatively few ways to define the 
structure of inhibited and catalytic RNR complexes in solution.11-12  Here, reaction-induced 
FT-IR spectroscopy was applied to define conformational motions in RNR that are linked 
to catalysis and to inhibition with HU and dATP.  
2.5.2 Secondary structural changes accompany formation of the QC.   
Our data indicate that mixing of 2 and β2 in the presence of ATP, CDP, and DTT 
alters hydrogen bonding and secondary structure both in 2 and β2.  X-ray structures of 
2 show three structural domains (Figure 2.1 C).  The N-terminal, alpha helical dATP 
binding domain is a four-helix bundle that is capped with a small beta sheet.  The other two 
domains are a central, 10-strand alpha/beta barrel, which contains the essential thiyl radical 
essential in a beta loop, and a smaller 5-strand alpha/beta barrel.  The two active site 
cysteines that reduce substrate are found on adjacent beta strands to the beta loop.  The 
specificity site is found at a four-helical bundle interface between the two  monomers.  
Allosteric control is mediated by changes in conformation in the flexible loops at the 
specificity site.14 
2.5.3 Amide I bands at 1681, 1672, and 1643 cm-1 are dATP/ATP sensitive.   
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Our reaction-induced FT-IR spectra show that formation of the QC is associated 
with changes in the frequency and intensity of 2 and β2 amide I bands.  From the 
frequencies, the observed amide I bands at 1681 and 1671 cm-1 (Table 2.1) were assignable 
to hydrogen bonding changes involving antiparallel and parallel beta strands.57-62  A band 
at 1643 cm-1 was assigned to disordered secondary structural regions.  The intensities of 
the 1681, 1671, and 1643 cm-1 bands were dependent on the presence of ATP, these bands 
were not observed when dATP is bound to the activity site.  These ATP/dATP-sensitive 
bands are therefore assignable to a transition from a disordered to a beta strand domain, 
which accompanies formation and turnover in the QC.  dATP binding is known to prevent 
formation of the active complex, to promote the formation of inactive oligomers, and to 
bind at the specificity site.11-13   X-ray crystallography has shown that the structure of a 
loop (loop 2, see Figure 2.1 C) in the specificity domain is sensitive to occupancy at this 
binding site.37, 70-71  The ATP/dATP-dependent 1681, 1671, and the 2 component of the 
1643 cm-1 band can be accounted for by such a conformational change in loop 2. The 
intensity of the β2 amide band at 1643 cm-1 was also dATP/ATP sensitive.  The β2 subunit 
is primarily alpha helical, but the carboxyl terminal domain, which binds to 2, is 
disordered and not resolved in X-ray structures.16, 38 The loss of intensity in the 1643 cm-1 
β2 band may reflect decrease in disorder in the QC, due to the formation of contacts 
between 2 and β2 in the QC.  These data provide evidence for activity-induced, 
conformational rearrangements in the 2 and the β2 subunits.    
2.5.4 Amide bands at 1691, 1661, and 1622 cm-1 are not dATP/ATP sensitive.   
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The 1691, 1661, and 1622 cm-1 bands may represent internal 2 and β2 hydrogen 
bonding changes associated with ATP/dATP binding or with CDP binding under reducing 
conditions.13-14, 37   
2.5.5 Formation of the QC alters the frequency of dATP/ATP sensitive 2 and β2 
carboxylate bands.   
Our data identified isotope-sensitive bands at 1425, 1414, and 1400 cm-1 in 2, 
which are altered in frequency and intensity in the QC.  These bands arise from the 
symmetric stretch of carboxylate side chains.  Overlapping carboxylate bands at 1425 and 
1414 cm-1 arise from β2 (Table 2.1).  The intensities of these carboxylate bands were 
altered by dATP, suggesting that the environment of these carboxylates is modulated by 
formation of the QC and turnover.  Therefore, these carboxylates may be located at the 
2β2 interface.  The β2 linker peptide, which interacts with 2 to form the 2β2 quaternary 
complex, includes one glutamate and four aspartate residues. 2 also contains carboxylate 
residues (including Asp: 227, 520, 608, 630, Glu: 224, 231, 281, 519, 524) that may be 
located at the 2β2 interface.23  
2.5.6 The Y122 and D84 structural landscapes are similar in 2β2 and isolated β2. 
Reaction-induced FT-IR spectra also monitored the HU reaction in the QC.  HU 
reduces Y122O• in a PCET reaction, leading to vibrational bands from radical and singlet 
in the reaction-induced spectrum.  The isotopic chimera, in which the β2 subunit was 2H4Y 
labeled, was employed to assign bands to β2 tyrosines.  As in isolated β2, (Figure 2.6 B 
and ref 50) the 1498 and 1514 cm-1 bands, which are characteristic of Y122O• (Y7a) and 
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Y122OH (Y19a), were observed with 2H4Y labeling (Table 2).  The similarity of the 
frequencies suggests that hydrogen bonding environments of Y122O• and Y122OH are 
similar in isolated β2 and in the 2β2 complex. Bands at 1687 and 1675 cm-1 bands were 
observed in the β2 subunit after formation of the QC (Table 1). These bands were 
previously assigned to the asymmetric carboxylate stretching mode of β2 D84 by 13C 
aspartate labeling in the isolated β2 subunit.46 D84 is a unidentate ligand to the iron cluster 
and undergoes a coupled hydrogen bonding change when Y122O• is reduced.  The 
frequency of the asymmetric stretching vibration is a marker for this hydrogen bonding 
change, which occurs in isolated β246 and also, as shown here, in the QC.  In the QC, the 
D84 bands overlap with 2 bands, but the contributions can be evaluated separately in the 
13C2β2 and 213Cβ2 chimeras.   Global 13C labeling of β2 also reveals amide I bands 
(Table 2.1) previously assigned to D84, Y122O•, and Y122OH in isolated β2.39, 46  When 
compared to density functional theory calculations, these data support a redox-linked 
conformational change from the A (singlet) to the B (radical) conformer of Y122 (see 
Figure 2.1B).  Observation of these bands in the QC indicates that redox-driven structural 
changes at Y122 and D84 are relevant to catalysis. 
2.5.7 In the QC, HU reduction alters secondary structure in 2.   
In addition to changes in β2, HU reduction led to structural changes in 2, as 
assessed by the appearance of 2 1685/1675 cm-1 bands in the HU-edited spectrum of the 
QC (Table 2.1).  These results demonstrate that the 2 subunit is conformationally 
malleable and responsive to the HU-mediated reduction of Y122O•.    
2.5.8 Evidence for a conformationally active β2 tyrosine, Yx.   
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Our data provide evidence that a second β2 tyrosine, termed Yx, undergoes a 
structural change when the QC forms or when HU is used to reduce the QC.  HU-editing 
and 2H4Y labeling of the β2 subunit led to the detection of these additional tyrosine bands 
at (–) 1521 and (+) 1501 cm-1 (Figure 2.6 C).  These spectral features have a frequency and 
an isotope shift (Table 2.2) consistent with assignment to a tyrosinate ring stretching 
vibration, Y19a, in two different environments. Tyrosine ring vibrations are known to be 
altered in frequency by changes in side chain protonation and hydrogen bonding.  For 
example, a model compound, tyrosine in solution, was reported to have a Y19a band at 
1518 cm-1, while tyrosinate had a Y19a band at 1499 cm-1.72  Thus, the (+) 1501 cm-1 band 
in Figure 2.6 C, may represent a tyrosinate species, Yx-, and the negative (–) 1521 cm-1 
band arise from tyrosine, Yx.  The isotope-shifted bands are assigned with opposite sign at 
(–) 1455/1436 and (+) 1414 cm-1 (Figure 2.6 C, Table 2.2).  Note that the another ring 
vibrational mode, Y8a, expected at ~1600 cm-1, may be observable, but is expected to be 
much less intense compared to Y19a.68, 72 Interestingly, 2H4Y labeling also altered the 
spectrum obtained after mixing 2 and β2 in the presence of ATP, CDP, and excess 
reductant (Figure 2.3 D) with no HU.  Similar bands were observed at 1521, 1501, and 
1414 cm-1 (Figure S4 C).  This result provides support for the conclusion that a 
conformational change at Yx is associated with formation of the QC.  This conformational 
change may be a Yx protonation reaction.  One possible explanation is that the spectra 
reflect a protonation change at β2 Y356, which is known to be required for intersubunit 
PCET.26  However, site-selective NO2Y modification has shown that the pKa of Y356 is 
not perturbed in the QC or in isolated β2.30, 73  Alternatively, more modest shifts in Y19a 
frequency have been associated with changes in hydrophobicity in the RAS protein.74  The 
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sign of the Yx bands is of interest.  In the experiment described in Scheme 2.2, part II, i.e., 
mixing to form the QC, the 1521 cm-1 band is positive and the 1501 cm-1 band is negative 
(Figure S4C).  This sign change is consistent with an increase in hydrophobicity or a 
protonation of Yx, when the QC at t1 (Scheme 2.1, part I) is compared to the sample after 
the consumption of substrate (t2).  In this experiment, one isotope-shifted band at 1455 cm-
1 is observed.  In the isotope-edited and HU-edited spectrum (Scheme 2.2, part IV, HU-
minus-no HU), the signs of the 1521 and 1501 cm-1 bands were reversed, as expected if the 
conformational change occurs in the QC.  Interesting, two putative isotope-shifted bands 
were observed at 1455 and 1436 cm-1 (Figure 6 C, Scheme 2.1, part IV).  The origin and 
assignment of Yx bands will be investigated in future studies. 
2.5.9 HU-editing and 2H4Y tyrosine labeling reveals complexity in the amide I region of 
the QC.   
2H4Y isotope- and HU-editing in the QC led to a change in the amide I region, when 
the spectra were compared to data acquired from 2H4Yβ2 alone.  Side chain labeling can 
alter amide frequencies if the vibrational motions are similar in frequency and coupled.46  
For example, 2H4Y sensitive amide I bands were observed in photosystem II (PSII), which 
contains two redox-active tyrosines.  Reaction-induced FT-IR spectra, collected for the 
redox active tyrosine, YZ, revealed amide I contributions that were shifted by tyrosine ring 
labeling.75 The 2H4Y-sensitive bands were attributed to redox-linked backbone dynamics,75 
which may also occur for Yx .This suggestion that Yx is conformationally flexible in the 
QC may be consistent with an assignment to Y356 in β2.  Y356 is located in a C-terminal 
domain of β2 that is not resolved in the crystal structure.16, 38  This C-terminal domain 
interacts with the 2 subunit.76 Recently, it was shown that Y356 has a relative redox 
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potential, which is (~100 mV) lower than the active site cysteine in 2.35 Thus, a forward 
electron transfer, mediated by Y356, is thermodynamically uphill and likely to be 
conformationally gated.30 
2.5.10 Inhibitors of RNR, HU and dATP.   
In this paper, experiments employed the RNR inhibitors, HU and dATP.  HU is a 
clinically-relevant anti-cancer and anti-viral treatment.77 In E. coli, HU reduces Y122O•, 
but retains the differic cluster. Kinetic experiments show no saturation of HU on the 
reaction, suggesting HU has no specific interaction with β2.63 However, a  mutation at a 
β2 surface residue near Y122 generates HU resistance, supporting direct electron transfer.78 
Consistent with this, the HU reaction in isolated β2 is associated with a large solvent 
isotope effect.39 In the quaternary complex, HU-mediated Y122O• reduction is 10-fold 
faster compared to the rate in isolated β2.64 It was hypothesized that HU participates in 
multiple reduction pathways, one of which is the physiologically-relevant PCET 
pathway.79  Our results agree with this suggestion, because the HU reduction pathway in 
the QC involves a secondary structure change in 2, as well as secondary structural 
changes in β2. In E. coli class Ia RNR, dATP is a reversible inhibitor that modulates the 
overall activity of the enzyme by interaction with the N-terminal activity site. X-ray 
structures of a 2-AMPPNP complex showed no significant changes associated with 
binding of this compound to the activity site.37  However, dATP also binds to the specificity 
site, which contains a conformationally flexible loop region.80  The structure of this loop 
is specific to the bound effector.70  In our reaction-induced FT-IR spectra, ATP promoted 
secondary structural changes in 2, which were inhibited by dATP.  The frequencies and 
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signs were consistent with a change from beta sheet (initial state, QC) to disordered 
structure (final, substrate consumed state).  dATP inhibits this conformational change, 
mostly likely caused by binding interactions at the specificity sites.  X-ray structural data 
have provided evidence for a loop 2 structural change when the effectors, dTTP, dATP, 
and dGTP, are bound to the specificity site.  In class II 2, loop 2 is disordered until 
deoxynucleotide binding induces ordering and alters main chain interactions.14, 70, 80 This 
pattern of allosteric control also occurs in the class Ia enzymes.13, 80  The reaction-induced 
FT-IR technique provides a novel way to monitor these conformational rearrangements in 
the QC. 
2.6 Conclusions   
Proteins exhibit conformational motions on multiple timescales, this dynamic landscape 
facilitates catalysis and provide opportunities to design specific inhibitors.81-84 NMR 
describes these motions, but this technique is typically limited to small, diamagnetic 
proteins. FT-IR spectroscopy can be applied to large, complex proteins and provides high 
signal-to-noise, which allows spectral assignment at single amino acid resolution.  This 
method is facilitated by the use of isotope-edited spectra in which spectral assignments are 
based on specific isotopic labeling.  Reaction-induced FT-IR spectroscopy provides an 
incisive, new method to describe the RNR structural landscape. 
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Overall work contributed to this project includes the overexpression of both the α2 and 
β2 subunits involved in all experiments. This work involves the expression of the natural 
abundance as well as the isotope labeled samples. I was also responsible for the 
purification of each subunit involving column chromatography procedures discussed in 
the text. I was further involved in the discussion of experimental FT-IR spectroscopy 
results obtained with these purified samples.   
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CHAPTER 3. INVESTIGATION OF STRUCTURAL BINDING 
INTERACTIONS IN E. COLI RIBONUCLEOTIDE REDUCTASE 
3.1 Abstract 
Ribonucleotide reductase (RNR) is a multiple subunit enzyme solely responsible 
for the production the deoxyribonucleotides from the corresponding ribonucleotides 
required for both DNA replication and repair. RNR supplies cellular deoxynucleotide 
triphosphate (dNTP) pools by using a stable radical cofactor to convert nucleotides to 
deoxynucelotides.1-3 Class Ia RNR consists of homodimeric α2β2 active complex.4 The β2 
subunit contains a stable Y122O• differic cofactor.5-7 Long-range proton-coupled electron 
transfer generates a transient C439• located 35Å away in the active site of the functional 
α2β2 complex.3, 8-10 The conformational effects related to substrate (CDP/UDP) and 
effector (ATP/TTP) binding to the active and specificity sites, respectively, are studied by 
reaction-induced FT-IR difference spectroscopy. Hydroxyurea (HU) and Fe(II)-Triapine 
(Fe(II)-3AP) are two radical scavengers that inhibit α2β2 by quenching the tyrosyl radical.  
Investigation of the reduction mechanism by HU and Fe(II)-3AP describe the 
conformational changes associated with the inhibited enzyme complex. Previously, we 
identified an aspartate 84 contribution is observed with HU inhibition.11-12 This assignment 
was further investigated using a potent inhibitor, Fe(II)-3AP. Conformational 
rearrangements that take place during catalysis mask the radical chemistry from direct 
observation.  Radical trap 2′-azido-2′-deoxyuridine 5′-diphosphate (AzUDP) isolates the 
radical in the active site near C439 and prevents reformation of the resting state Y122O•. 
Conformational changes associated with the radical “hole” being propagated to the active 
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site can be seen for the first time. Amide I (C=O) and II (CN/NH) bands were observed as 
well as the previously identified Asp84 during inhibition. The addition of the effector ATP 
resulted in the appearance of bands 1872 and 1040 cm-1, likely due to increased interactions 
between the substrate binding in the specificity site and the induced conformational 
response by nearby protein backbone. This ordered structure is not observed upon 
incubation with the effector TTP. Under HU inhibition a band at 1687 cm-1 was previously 
assigned to D84 hydrogen bond formation with Y122OH. However, upon inhibition by 
Fe(II)-3AP this band is no longer present, but displays negative features seen at 1633 and 
1624 cm-1. Spectral similarities are observed between AzUDP-inhibited and HU-inhibited 
complexes. Contributions at 1687, 1657, and 1649 cm-1 which have been previously 
assigned as D84 amide I vibrational modes in isolated β2 have never been seen in AzUDP-
inhibited α2β2. RIFT-IR difference spectroscopy exposes how the inhibitors HU and 
Fe(II)-3AP interact with the active α2β2 complex in different methods to accomplish the 
indistinguishable radical quenching in isolated β2. The distinctive inhibitor, AzUDP, 
induces structurally significant rearrangements due to radical generation in the active site 
resulting in the formation of a hydrogen bond between Y122OH and D84 and deconvolutes 
conformational masking. 
3.2 Introduction 
In all organisms, ribonucleotide reductase (RNR) drives the production of 
deoxynucleotides by using a diiron metallo-cofactor and molecular oxygen to generate a 
stable radical species. RNR is the enzyme responsible for preserving the proper ratios of 
dNTP reservoirs for DNA synthesis and repair.13-15 If these cellular concentrations were to 
become imbalanced, the fidelity of DNA decreases leading to point mutations and 
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ultimately genomic instability.16 Due to its necessity for cell replication, the over 
production of RNR in cancerous tissue has characterized it as a key target for 
chemotherapeutics.17 In its active form, RNR is composed of two homodimers, α2 and β2 
(Figure 3.1). The α2 can be separated into two domains. The N-terminal-domain of the α2 
subunit contains the activity site, a site of allosteric regulation.18-19 The catalytic body 
encompasses a different site of allosteric regulation, the specificity site, and the catalytic 
active site. The allosteric sites tightly synchronize RNR activity.20 Adenosine triphosphate 
(ATP) binding to the activity site induces conformational changes and increases RNR 
production. Comparatively, when dATP binds to the N-terminal-domain an overall 
decrease in activity is observed. The binding of distinct effectors to the specificity site 
triggers unique conformational responses from loops 1, 2, and 3 and results in the binding 
of CDP, UDP, GDP, and ADP substrates for reduction.21-22 Catalysis in 2 is driven by the 
binding of substrate and effectors leading to the formation of the QC.23-24  
Class Ia RNRs are comprised of human and E. coli RNRs and contain fundamental 
amino acids necessary for radical initiation. In vitro, E. coli RNR retains the β2’s ability to 
store the radical at Y122 (E. coli) until turnover is initiated by allosteric regulation. A 
conserved radical transfer pathway between the active site and the radical generation site 
is required in both human and E. coli RNR. The conformational changes in the E. coli α 
and β subunits during catalysis and inhibition will be explored. 
These studies are conducted using E. coli RNR as a model RNR. Identifying how 
the α subunit responds to substrate and effector binding will uncover a discernable and 
detectable conformational response from if ATP is bound in the specificity site versus if 
TTP is bound. The diferric cluster, molecular oxygen, and a conserved tyrosine residue, 
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Y122 in the β2 subunit (Figure 3.1 B) are necessary to generate the radical responsible for 
nucleotide reduction. However, nucleotide reduction takes place 35 Å away from where 
the radical is generated. Production of dNTPs is carried out in the active site of the larger 
α2 subunit.3-4, 25-26 Various forms of cancer and other oxidative stress related diseases have 
all been linked to free radical production in the body.27-29 Free radicals form naturally from 
biological processes and rigorous exercise,5, 30-31 as well as being induced by commonly 
used house hold chemicals32 and global pollution.33 However, formation of high 
concentrations of free radicals can cause a cascade that can produce cellular damage, 
ultimately leading to genomic instability if antioxidants are not present in sufficient 
concentrations.34 Evolution has selected organisms that exploit the power of free radicals 
to drive the assembly of deoxynucleotides to maintain nucleotide concentrations for DNA 
synthesis and repair.35-36  
 
Figure 3.1 (A) Structure of α2 subunit at 3.2 Å (PDB 4R1R) containing substrate 
(green) GDP in the active sites and effector (blue) TTP bound to the specificity sites. 
This subunit is the site of nucleotide reduction.  (B) Structure of β2 subunit at 2.2 Å 
(2XOF), the Fe-O-Fe clusters responsible for radical generation at Y122 are shown in 
orange (iron) and red (oxygen). 
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After the radical is generated by the diferric cluster, the radical hole must be 
transported 35 Å from the β subunit, across the α:β interface, into the α subunit, and finally 
resides on the conserved cysteine-439 (C439) residue in the catalytic site. The radical 
transfer pathway has been studied extensively using the incorporation of unnatural amino 
acids, as well as different types of experimental techniques.8-9, 37-45 This has led to 
compelling evidence of a well-established radical hopping pathway. 9-10, 46 This pathway is 
proposed as follows: β-Y122O• → β-Y356 → α-Y731 → α-Y730 → α-C439 allows for 
reversible, long-range proton-coupled electron transfer (PCET). Rapid transfer is gated by 
conformation responses of the enzyme that are not fully understood, however, recent work 
suggests the protein dynamics are directly related to an iron bound water ligand to the 
diferric cofactor supplying the proton in the concerted PCET reaction to Y122O•.47 Y356 
provides the electron in the long-range PCET that fills the radical hole and propagates this 
radical into the active site. Interestingly, proton and electron donation differ from the α to 
the β subunit, where proton and electron transfer occurs orthogonally in the β2 subunit but 
occurs collinearly in the α2 subunit. Once the radical is in the active site, C439• induces 
reduction of the nucleotide substrate and release of the deoxyribonucleotide for DNA 
synthesis or repair. After release of the product, the pathway is used to reform the stable 
Y122O• by reversible PCET.43, 48 Despite high-resolution crystal structures of the β2 
enzyme, there remains no specificity regarding the position of β-Y356 due to the high 
variability of the C-terminal tail in isolated β2.49  
The inhibition of RNR has been a major focus in cancer treatment to control and 
inhibit the overexpressed activity of RNR in cancerous cells. Chemical inhibition of the 
active quaternary complex (QC) using substrate and effectors has been of great interest to 
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understand the interactions that lead in RNR inactivity.50-52 The mode of inhibition of RNR 
is significant for the design and applications of innovative anti-cancer therapeutics, like 
radical scavengers hydroxyurea (HU) and Triapine (3AP).53-54 In contrast to HU and 3AP, 
2′-azido-2′-deoxyuridine 5′-diphosphate (AzUDP) acts as a radical trap in the active site, 
generating a nitrogen radical that is moderately stable (Figure 3.2 A).55-56 AzUDP and 
gemcitabine, a FDA approved cancer therapeutic in that they both inhibit with the α2 
subunit.57 Gemcitabine competes with dCTP for incorporation into DNA during synthesis 
and prevents the reformation of the essential radical for substrate reduction.58 Gemcitabine 
is can be used with cisplatin to treat various forms of cancerous cells.40, 59-60 Cisplatin 
creates cross links in DNA to prevent DNA synthesis and trigger apoptosis.61 Although 
AzUDP is not being proposed as a potential option for cancer treatment in this study, we 
are proposing its uses to unmask the conformational changes associated with PCET.11, 47, 
62-63 COH29 is a promising inhibitor that binds to the ligand binding pocket of β2, 
preventing the formation of the α2β2 complex.64 Other promising inhibitors that prevent 
protein-protein contact formation have been discovered using peptidomimetic compounds 
that have shown antiviral activity with HIV.65  Another possible avenue for investigating 
RNR would be with iron chelators that cause radical loss by depletion of intracellular iron 
concentration,66-67 and could be a direction pursued in future work. As seen in Figure 3.2 
B, reaction-induced Fourier transform infrared (RIFT-IR) difference spectroscopy allows 
for the detection of subtle perturbations as small as a single amino acid conformational 
changes in RNR as a result of catalysis or inhibition due to radical quenching or trapping.68-
71 The FTIR spectra highlight the distinction of protein conformations in the presence of 
different substrates and effectors during active turnover noticing key features of the spectra 
 94 
to occur independently of whether the enzyme is active or inhibited, and the conformational 
significance of QC inhibition. 
 
Figure 3.2 (A) A tyrosyl radical, Y122O•, is generated by an oxygen requiring diiron 
cluster and is required for catalysis. Separate modes of inhibition, radical quenching 
and trapping, are illustrated. HU and Fe(II)-3AP quench the tyrosyl radical 
prohibiting substrate reduction. AzUDP acts as a substrate analog and allows PCET 
to occur and generate a nitrogen centered radical (N•). (B) Method to generate 
reaction-induced FTIR difference spectra. These regions investigated have amide and 
carboxylate (COO−) vibrational mode contributions. 
3.3 Materials and Methods 
3.3.1 Materials.  
Hydrochloric acid (HCl), HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid, and sodium hydroxide (NaOH) purchased from Sigma (St. Louis, MO) were used for 
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experimental and purification buffer solutions. UV-Vis kinetic experiments and FTIR 
spectroscopy samples were prepared in deuterium oxide (D2O, 98%) and pH was adjusted 
using sodium deuteroxide (NaOD, 99.5%) to pD 7.6. Samples were obtained from 
Cambridge Isotope Laboratories (Andover, MA). Triapine (3AP) was a gift from Alan C. 
Sartorelli, Yale (New Haven, CT). 2′-azido-2′-deoxyuridine 5′-diphosphate (AzUDP) was 
a gift from Lisa Olshansky and JoAnne Stubbe, MIT (Cambridge, MA). Hydroxyurea (HU) 
was acquired from Calbiochem (San Diego, CA).  
3.3.2 Overexpression and isolation of RNR E. coli α2 and β2 homodimers.  
BL21 cells containing N-terminal His6-tagged α2 were overexpressed and purified 
by Ni-NTA column chromatography. Wild-type β2 was overexpressed using BL21 cells 
and purified using size exclusion and ion-exchange chromatography. Identification of 
purified α2 or β2 was performed by gel electrophoresis. Average yield of β2 was 20 mg/g 
of cell paste. UV−Visible absorbance spectroscopy was used to calculate the 
concentrations of the α and β dimers with the extinction coefficients, 280 = 189 mM-1 cm-
1 and 280 = 131 mM-1 cm-1, for α2 and β2, respectively. The drop-down baseline method 
was used to quantify the concentration of tyrosyl radical (Y122O•) in β2 spectroscopically, 
and the average value was 1.19 Y122O•/β2. 
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Figure 3.3 (A) FT-IR absorption spectra. Substrates, effectors, and inhibitors were 
tested to identify specific individual contributions in each spectrum. (B-D) Structures 
of inhibitors used throughout this study. Hydroxyurea, Fe(II)-3AP, and AzUDP, 
respectively. 
3.3.3 Decay kinetics of Y122O• by UV−Vis spectroscopy  
Kinetic analysis of tyrosyl radical reduction was monitored with a Varian Cary 50 (Varian, 
Walnut Creek, CA) spectrophotometer at 20°C by use a Peltier cell. The QC mixing 
experiments involved 35 μM α2, 35μM β2, 3 mM CDP (or 1 mM UDP/AzUDP), 1 mM 
ATP (or 0.8 mM TTP), 5 mM DTT, 15 mM MgSO4, 1 mM EDTA, and 50 mM HU or 40 
μM Fe(II)-3AP, where applicable, in 5 mM HEPES, pD 7.6 buffer (300 μL final volume). 
All samples were prepared in D2O. Turnover and inhibition trials were prepared identically 
as follows: DTT, MgSO4/EDTA, ATP (or TTP), CDP (or UDP/AzUDP), α2, and finally, 
β2 was added to initiate radical transfer. Fe(II)-3AP was prepared in D2O in the presence 
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of oxygen with equal amounts of FeCl3 and 3AP. DMSO was used to increase the solubility 
of 3AP and excess DTT was present in solution to continuously reduce the Fe(III)-3AP to 
Fe(II)-3AP. AzidoUDP was prepared in 5mM HEPES, D2O.  Inhibitor samples were stored 
at -80ºC until ready for use. Figure 3.2 A describes the conditions under which RNR is 
studied in this investigation. When inhibitors were present, they were added immediately 
following β2 addition to reduce Y122O•. The sequence of addition, including inhibitors, is 
consistent with FT-IR spectroscopy experiments discussed below. In the absence of 
inhibitors (Figure 3.4 A, 3.4 C, 3.5 A, and 3.5 D), no discernable change was observed for 
radical concentration during kinetic analysis. In Figure 3.4 (B, D, isolated β2), and 3.5 (B, 
C, E, α2β2), a monoexponential fit was used to calculate the rate constants of tyrosyl radical 
reduction by hydroxyurea by measuring the absorbance of 410 nm over time, a 
characteristic band of the tyrosyl radical. The concentration is displayed as percent 
remaining radical concentration as a function of time. Figure 3.6 uses Fe(II)-3AP and 
AzUDP, that inhibit the enzyme by radical quenching and radical trapping, respectively. It 
can be seen clearly that, in each case, both therapeutics result in loss of the tyrosyl radical 
over the course of kinetic analysis. Baseline drop-down method: [Y122O•] = (A411nm − 
[(3(A416nm) + 2(A406nm))/5)/(1784 M
-1 cm-1) was used to evaluate the radical concentration. 




Figure 3.4 UV-Vis kinetic spectroscopic studies of (A) 40 μM isolated β2 and (B) 40 
μM isolated β2 with 50 mM HU (C) Measure of percent radical present in A over the 
course of the 30-minute runs. (D) Measure of percent radical in B that is subsequently 
quenched by HU over the course of 60-minute runs. Averages: (A) 12 and (B) 11. 
 
Figure 3.5 UV-VIS kinetic spectroscopic radical scavenger (HU) mixing studies (A) 
35 μM α2, 35 μM β2, 1 mM ATP (0.8 mM TTP), 3 mM CDP (1 mM UDP) with no 
inhibitor. (B) 35 μM α2, 35 μM β2, 1 mM ATP, 3 mM CDP, and 50 mM HU. (C) 35 
μM α2, 35 μM β2, 0.8 mM TTP, 1 mM UDP and 50 mM HU. (D) Measure of percent 
radical in A over the course of 30-minute runs. (E) Measure of percent radical in B 
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and C that is subsequently quenched by HU over the course of 30-minute runs. 
Averages: (A) 9, (B) 9, and (C) 9. 
 
Figure 3.6 UV-Vis kinetic spectroscopic studies of radical scavenger (Fe(II)-3AP) and 
radical trapping substrate analog (AzUDP) (A) 35 μM α2, 35 μM β2, 1 mM ATP, 3 
mM CDP and 40 μM Fe(II)-3AP. (B) 35 μM α2, 35 μM β2, 0.8 mM TTP, and 1 mM 
AzUDP. (C) Measure of percent radical quenched in A over the course of 30-minute 
runs. (D) Measure of percent radical in B that is trapped in the active site over the 
course of 30-minute runs. Averages: (A) 9 and (B) 9. 
3.3.4 Reaction-Induced FT-IR Spectroscopy.  
A temperature-controlled Nicolet Magna 550 II spectrometer was used to collect reaction-
induced FT-IR spectra (Nicolet, Madison, WI). All of the FT-IR spectra shown in this work 
were collected at 20°C using a MCT-A detector. All reaction-induced FT-IR mixing 
samples were prepared in deuterium oxide (D2O) with the final concentrations of 100 μM 
α2, 100 μM β2, 3 mM CDP (or 1 mM UDP/AzUDP), 1 mM ATP (or 0.8 mM TTP), 5 mM 
DTT, 15 mM MgSO4, and 1 mM EDTA in 5 mM HEPES (pD 7.6) in the final 300 μL 
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sample. Figure 3.3 shows absorbance spectra of all substrates, effectors, and inhibitors that 
were collected to disregard any contributions not specifically from QC interactions. 
Immediately upon addition of either the β2 subunit for turnover or an inhibitor to quench 
the radical, a computer-controlled pump injected the prepared sample into the CaF2 flow 
cell with a path length of 50 μm. Data was collected for difference spectroscopy for 2 min 
followed by 6 min of incubation, followed by another 2 min of data collection. This 
experimental parameter as well as inhibitor concentration was decided on based off the 
half-life of tyrosyl radical reduction monitored by UV-Vis absorbance kinetics to maximize 
signal intensity to baseline drift. Each 2 min scan was performed using a 4 cm-1 resolution, 
collection of 595 total interferograms, and a mirror velocity of 2.53 cm s-1. Happ−Genzel 
apodization function, two levels of zero filling, and a Mertz phase correction were used for 
Fourier transform and generation of the energy spectra. A ratio to a previously collected 
open beam composed of the empty CaF2 flow cell windows and the energy spectra 
generated the absorption spectra.  The difference of each absorption spectra from each 10 
min scan was taken to generate the difference spectra (t1-minus-t2). All subsequent 
absorption spectra were collected and processed identically to show individual 
contributions based on the substrate, effector or inhibitor.  
3.4 Results 
3.4.1 UV-Vis spectroscopic analysis of tyrosyl radical reduction 
3.4.1.1 2 with radical scavenging hydroxyurea 
UV-Vis spectroscopy is used to optimize RIFT-IR spectroscopy to examine 
ribonucleotide reduction. Here we monitor E. coli 22 radical which has a characteristic 
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410 nm peak coupled with a shoulder band at 390 nm. In these spectra we also see 
contributions from the diferric metallo-cofactor at 325 and 375 nm. In Figure 3.4 B, we 
present UV-VIS derived kinetic studies of isolated 2 with HU and the characteristic 
spectra, single reduction by HU. The band contributed a sharp radical peak at 410 nm. This 
is compared to Figure 3.4 A where HU was not added. In C and D, the data have been 
converted to % tyrosyl radical with the baseline drop down approach. Kinetics shows that 
in Figure 3.4 B, 50% percent of the radical has been reduced by HU in the given parameter. 
Without HU there is no reduction of the radical. This is consistent with previous results. 
3.4.1.2 E. coli 22 with various substrates, effectors, and inhibitors 
In Figure 3.5, we add 2, along with substrates and effectors to examine the 
inhibition by HU in the active complex. Figure 3.5 A, serves are a control where 2, 2, 
substrates (CDP or UDP) and effectors (ATP or TTP) were mixed together without 
inhibitor. In Figure 3.5 B, mixing of 2, 2, ATP, CDP, and HU. In Figure 3.5 C, mixing 
of 2, 2, TTP, UDP, and HU were monitored by UV-VIS spectroscopy. Figure 3.5 D and 
E involve conversion of the data to % tyrosyl radical with the baseline drop down approach. 
In Figure 3.5 E, (•) represents ATP and CDP and () represents TTP and UDP, both of 
which have no inhibitor, and there is no radical reduction observed. In Figure 3.5 F, HU 
has been introduced into the solution, and with ATP and CDP (•) and TTP and UDP (), 
35 to 40% tyrosyl radical has been reduced over the course of the 10-minute experimental 
run, respectively. 
 In Figure 3.6, we introduce two separate inhibitors to the QC, a radical 
scavenger Triapine (3-AP) and a substrate analog azido-2′-deoxyuridine 5′-diphosphate 
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(AzUDP). In Figure 3.6 A, the 2, 2, ATP, CDP, and active form, Fe(II)-3AP (discussed 
in Figure 3.25), show the sharp radical peak at 410 nm being reduced of over the course of 
the 30-min reaction. In Figure 3.6 B, 2, 2, TTP, and AzUDP the tyrosyl radical has been 
amplified to observe the smaller loss in radical than has been previously discussed. In 
Figures 3.6 C and D, show data conversion to % tyrosyl radical. In Figure 3.6 C, 20% of 
the tyrosyl radical has been reduced over 10 minutes, as designated by the experimental 
design of the FT-IR spectroscopy. In Figure 3.6 D, there is ~20% tyrosyl radical reduction. 
3.4.2 Reaction-induced FT-IR difference spectra derived from 22/ATP/CDP mixing.  
Previously we examined clear distinctions between the contributions that results 
from isotopically labelled E. coli  and  subunits, where we looked at active turnover with 
a single substrate (CDP) and effector (ATP). 72 In addition, we exposed the active complex 
to the radical scavenging inhibitor hydroxyurea (HU). 12, 73 Here we look to build upon that 
work by examining additional substrates and effector, as well as investigating the 
consequences associated with inhibition of the active complex.  
 Ribonucleotide reductase has strict control over the active site in the  subunit by 
allosteric regulation in the specificity site. 13-14, 74 Using two different effectors, ATP and 
TTP, allows the observation of how the binding of these effectors influence the spectra 
during active turnover or inhibition conditions (Figure 3.7). This figure displays 1750-1450 
cm-1 region of the FTIR spectra composed of amide and carboxylate vibrations. The amide 
I (C=O) frequency is sensitive to changes in hydrogen bonding and secondary structure (-
helix, -sheet, and loop). All samples were either prepared or buffer exchanged into D2O 
to shift the water bending mode whose contributions are so large that it would wash out the 
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protein amide I region. Deuterium exchange will also shift the CN and NH contributions 
to 1450 and 1000 cm-1, respectively allowing for clearer spectral assignments.  
3.4.3 Comparison of reaction-induced FT-IR spectra of the QC with altered substrate 
and effectors from 1750 to 1450 cm-1.  
In Figure 3.7, we present the average data corresponding to absorbance mixtures 
with ATP/CDP compared to TTP/UDP. Even under active turnover clear distinctions can 
be seen in Figure 3.7 B and D. When 2, 2, TTP, and UDP are mixed into solution and 
turnover occurs as seen in Figure 3.7 D, peaks can be seen at 1706 and 1685 cm-1 that were 
not previously observed with ATP and CDP. In Figure 3.7 B, 2, 2, ATP, and CDP, both 
of these peaks are absent from the spectra. However, bands seen at 1676 and 1659 cm-1 
with ATP and CDP display similar patterns and frequencies when compared to 1668 and 
1657 cm-1. The amide I (C=O) vibrations (1690-1620 cm-1) are sensitive to alterations in 
secondary structure. The large negative peaks at 1635 and 1618 cm-1 (Figure 3.7 D) are 
associated with the production of dUDP over the course of the experiment, as well as 
loop/unstructured regions (1640 cm-1). In Figure 3.7 B, these bands are similar at 1631 and 
1622 cm-1, however, with ATP and CDP, the spectrum has an additional negative band at 
1644 cm-1 unique to its turnover spectra. Additionally, both Figure 3.7 B and D contain a 
large positive peak at 1547 cm-1. In contrast, Figure 3.7 B, has an additional band with near 
equal intensity at 1527 cm-1 that is absent from Figure 3.7 D. Studies provide evidence that 
these signals could be a result of the modifications associated with the binding of the TTP 
in the specificity site.74-76 These changes suggest the ability to distinguish between active 
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turnover due to conformational responses to specific effectors in this highly regulated 
enzyme.  
 
Figure 3.7 Averaged α2β2 RIFT-IR spectra with and without HU were vertically 
offset for comparison: (A) 100 μM α2, 100 μM β2, 1 mM ATP, 3 mM CDP and 50 mM 
HU (B) 100 μM α2, 100 μM β2, 1 mM ATP, 3 mM CDP (C) 100 μM α2, 100 μM β2, 
0.8 mM TTP, 1 mM UDP and 50 mM HU (D) 100 μM α2, 100 μM β2, 0.8 mM TTP, 1 
mM UDP. Tick marks for the spectra are 2 x 10-3 absorbance units.  Averages: (A) 10 
(B) 9 (C) 7 (D) 6. 
3.4.4 Inhibition of the active 22 complex with radical scavenger, Hydroxyurea, from 
1750 to 1450 cm-1.  
In Figure 3.7, exposure of the QC to HU yielded results not previously seen with 
ATP and CDP compared to TTP and UDP. Inhibition of the quaternary complex (QC) by 
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HU was monitored by UV-VIS spectroscopy in Figures 3.4 (isolated 2) and 3.5 (22 
complex) to insure similar time scales of inhibition. In Figure 3.7 C, we still observe the 
1706, 1686, and 1668 cm-1 bands that previously observed in Figure 3.7 D. Observation of 
the 1706 cm-1 band in turnover and inhibition suggest the contribution could be due to 
binding of by substrate or effector to the 2 specificity or active sites. Where differences 
begin to appear between inhibition with TTP and UDP are at 1651 cm-1 which is 1657 cm-
1 in turnover reactions. Moreover, in Figure 3.7 C, there is a large, broad band with positive 
signals at 1626 and 1612 cm-1. In Figure 3.7 D, this region is negative with large peaks at 
1635 and 1618 cm-1 believed to correspond to dUDP production. Both Figure 3.7 C and D 
have large intensity peaks at 1547 and 1482 cm-1.  
In Figure 3.7 A and C, the data were derived from ATP and CDP (A), and TTP and 
UDP (C) with both holoenzymes being exposed to the inhibitor HU. These two inhibited 
structures display clear changes in the mid-IR. In Figure 3.7 C, the band at 1706 cm-1 is 
present as stated previously, but is absent in Figure 3.7 A. Other bands in the amide I region 
between the inhibited complexes are remain similar. In Figure 3.7 C, these bands are 1686, 
1668, and 1651 cm-1 compared in Figure 3.7 A as 1686, 1672, and 1654 cm-1. There are 
small shifts in some of these bands. Most likely due to slight changes in the electrostatic 
environment of the protein. As previously stated in Figure 3.7 C, there is a large, broad 
band with positive signals at 1626 and 1612 cm-1. In Figure 3.7 A, the spectrum has a 
similar negative region when compared to Figure 3.7 B and D with two negative bands at 
1644 and 1629 cm-1. Interestingly, the spectrum displays a solitary positive peak at 1614 
cm-1 similar to Figure 3.7 C’s 1612 cm-1. Both Figure 3.7 A and C show identical signals 
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at 1547 cm-1, but similar to the comparison of the active turnover complexes, the 1527 cm-
1 peak is absent from the inhibited TTP/UDP mixing spectrum. 
3.4.5 Reaction-induced FT-IR spectra associated with AzUDP inhibition from 1750 to 
1450 cm-1.  
The process of radical transfer into the active site happens too rapidly for direct 
monitoring and is conformationally masked by the protein. 2, 77 To overcome this obstacle, 
we implemented the use of a radical trap 2’-Azido-2’-deoxyuridine 5’-Diphosphate 
(AzUDP). AzUDP traps the radical in the active site and, as a result, allows us to observe 
conformational changes associated with forward PCET in this conformationally “locked” 
state that would have been, previously, undetectable to us. 25-27 In Figure 3.8 A-C, we 
examined the effects of AzUDP with isolated 2 compared to HU. In Figure 3.8 A and B, 
we repeated previous results of isolated 2 with HU and with TTP, UDP, and HU, 
respectively. These spectra display previously assigned the iron ligand aspartate, D84, at 
1685 and 1675 cm-1 with contributions to the 1661 and 1653 cm-1 bands, as well as the 
Y122• at 1498 cm-1 and Y122OH at 1514 cm-1. However, in Figure 3.8 C, AzUDP shown 
in discernable interaction with isolated 2. This is expected as AzUDP should interact 
solely with the  subunits active site.  
In Figure 3.8 F, AzUDP spectra displays similar bands at 1685, 1674, and 1548 cm-
1 that are observed in all spectra regardless of substrate, effector, turnover or inhibition. It 
also exhibits a band seemingly unique to the presence of TTP and UDP at 1706 cm-1. This 
band is present in the active complex with TTP and UDP (Figure 3.7 D), the inhibited 
complex with HU (Figure 3.8 E) or AzUDP (Figure 3.8 F). Interestingly, AzUDP also 
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displays a negative band at 1657 cm-1 and a positive feature at 1649 cm-1. These bands are 
consistent with amide I vibrations indicating changes to the secondary structure and in 
hydrogen bonding. Under inhibition conditions in Figure 3.8 D and E, this region has 
remained positive around 1650 cm-1, which makes the negative band curious and unique 
to the substrate analog inhibitor. Clearly distinct from active QC (Figure 3.7 B and 3.7 D), 
as well as inhibition by HU (Figure 3.8 D and 3.8 E), this feature shows clear evidence of 
hydrogen bonding changes, conformational changes associated with PCET, and generation 
of a trapped radical species in the active site generated by way of AzUDP. The AzUDP 
spectrum also has two negative bands at 1640 and 1625 cm-1. These bands are interestingly 
more similar to Figure 3.8 D with ATP, CDP, and HU which correspond to 1644 and 1629 
cm-1, respectively whereas this region is positive in Figure 3.8 E. Figure 3.8 F, also displays 
the same loss of the peak at 1527 cm-1 that remains present under ATP and CDP conditions 
suggesting a contribution by ATP/CDP that is lost under TTP/UDP conditions. As a result 
of the radical having moved into the active site, clear conformational changes have 
occurred that are quite distinct from the active QC. AzUDP behaves as a substrate mimic 
in the active site of 2, 55-56, 68 but demonstrates conformational changes not detectable 
when the enzyme is left to function naturally. 
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Figure 3.8 Averaged α2β2 RIFT-IR spectra with HU and AzUDP were vertically 
offset for comparison (A) 40 μM β2 and 50 mM HU (B) 40 μM β2, 0.8 mM TTP, 1 
mM UDP, and 50 mM HU (C) 40 μM β2, 0.8 mM TTP, and 1 mM AzUDP (D) 100 
μM α2, 100 μM β2, 1 mM ATP, 3 mM CDP and 50 mM HU (E) 100 μM α2, 100 μM 
β2, 0.8 mM TTP, 1 mM UDP and 50 mM HU (F) 100 μM α2, 100 μM β2, 0.8 mM TTP 
and 1 mM AzUDP. Spectra D and E are reproductions of spectra in Figure 3.7 A and 
C, respectively. Tick marks for the spectra are 2 x 10-3 absorbance units. Averages: 
(A) 10 (B) 8 (C) 8 (D) 10 (E) 7 (F) 9. 
3.4.6 Inhibition of the active 22 complex with potent radical scavenger, Triapine from 
1750 to 1450 cm-1.  
Lastly, we wanted to examine another radical scavenging inhibitor similar to HU, 
but one that is far more potent, Triapine.53-54, 78-79 In Figure 3.9 A, control experiments were 
conducted, where iron was titrated into the 3AP sample and monitored by UV-VIS 
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spectroscopy to ensure that the 3AP was saturated at a 1:1 ratio. Titration of the iron from 
0.5:1 (black) up to 2:1 (blue) iron:triapine displays no UV-Vis changes once equal 
concentrations of triapine and iron are reached suggesting they form a 1:1 complex. Radical 
decay was monitored as previously reported and displayed in Figure 3.9 C and in Figure 
3.6 C based on % tyrosyl radical. In figure 3.9 B, additional controls were used to establish 
that Fe(II)-3AP was the active complex used to inhibit RNR. UV-VIS spectroscopy was 
used to monitor absorbance spectra generated by 3AP, Fe(III)-3AP, and Fe(II)-3AP. Both 
3AP (blue) and Fe(III)-3AP (aqua) show similar spectroscopic contributions with a sharp 
distinct band at 355 nm, Fe(II)-3AP (pink) is distinct in that it displays a broadening of the 
355 nm band seen with 3AP and Fe(III)-3AP and shifts its peak to 365 nm with a clear 
shoulder at 425 nm. Individual spectra were recorded for DMSO and DTT. DMSO was 
used to fully solubilize the 3-AP into solution. DTT was used to reduce the Fe(III)-3AP to 
Fe(II)-3AP based on absorbance spectra controls. 
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Figure 3.9 UV-VIS Spectroscopy 3AP controls and kinetic experiments. (A) Iron 
solution was titrated into 3AP containing sample to examine Iron:Triapine 
stoichiometry. (B) Absorbance spectra to determine individual spectral contributions. 
(C) 100 μM β2 and 40 μM Fe(II)-3AP in 5 mM Hepes, pD 7.6 over 30 minutes (Red: 
Indicates experimental start. Blue Indicates experimental end). 
Both HU and Fe(II)-3AP are radical scavengers and are thought to behave similarly 
when exposed to RNR.11-12, 52, 73, 80-83 In Figure 3.10 A and 3.10 B, isolated 2 FTIR 
spectroscopy display similar modes of inhibition by HU and Fe(II)-3AP, respectively. 
These spectra highlight D 85 bands at 1685 and 1675 cm-1, as well as amide I 
conformational changes at 1661 and 1653 cm-1 to which D84 also contributes. They both 
also feature Y122• at 1498 cm-1 and Y122OH at 1514 cm-1. Interesting to note, is that the 
concentrations used were 50 mM HU and 40 μM for Fe(II)-3AP. Nearly identical 
quenching of the tyrosyl radical done at over x1000-fold less in concentration. Could a 
binding site or multiple binding locations be the cause of such an increase in potency? 
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Figure 3.10 Averaged α2β2 RIFT-IR spectra for HU and Fe(II)-3AP were vertically 
offset for comparison (A) isolated 100 μM β2 and 50 mM HU (B) isolated 100 μM β2 
and 40 μM Fe(II)-AP (C) 100 μM α2, 100 μM β2, 1 mM ATP, 3 mM CDP and 50 mM 
HU (D) 100 μM α2, 100 μM β2, 1 mM ATP, 3 mM CDP, and 40 μM Fe(II)-AP. Tick 
marks for the spectra are 2 x 10-3 absorbance units. Averages: (A) 11 (B) 9 (C) 10 (D) 
8. 
These inhibitors were investigated further with the QC, as well, to see if Fe(II)-3AP 
displayed a similar potency, and if the inactivation of the QC was a similar to HU as it was 
observed in the isolated 2. In Figure 3.10 C and D, modes of inhibition do not appear to 
be as comparable as previously imagined. In figure 3.10 D, a discrete duo of peaks is 
observed in the amid I region at 1676 and 1657 cm-1. These two bands would correspond 
to 1672 and 1653 cm-1 as seen in Figure 3.10 C with HU. However, Fe(II)-3AP does not 
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have a positive band at 1886 cm-1. In both Figure 3.10 C and D, they both have negative 
bands at 1644, 1629 cm-1, and 1646 and 1633 cm-1, respectively, while Fe(II)-3AP has an 
additional negative feature at 1624 cm-1. The Triapine spectrum in Figure 3.10 D shares 
further similarities at 1602, 1584, 1542, 1531, 1514, and 1499 cm-1 to those seen in the HU 
Figure 3.10 C at 1614, 1584, 1547, 1527, 1514, and 1499 cm-1. The slight changes in 
wavenumbers suggest small variations in the electrostatic environments based on the 
different inhibitors.  
 
Figure 3.11 Averaged RIFT-IR spectra in the SD stretching region (A) α2, (B) β2, (C) 
β2 with HU, (D) α2β2, ATP, CDP with HU. (+) 1872 cm-1 band observed with α2β2, 
ATP, CDP with HU mixing experiment. The same band is not observed with isolated 
samples alone. Averages: (A) 7 (B) 6 (C) 11 (D) 10. 
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Figure 3.12 (A) 2, (B) 2, (C) 2 with HU, (D) 22, ATP, CDP with HU. (–) 1040 
cm-1 band observed with 22, ATP, CDP with HU mixing experiment. This negative 
feature is not observed with isolated samples alone. Averages: (A) 7 (B) 6 (C) 11 (D) 
10. 
3.4.7 Investigation of the active 22 complex from 2200 to 1800 cm-1, 1160 to 1000 cm-
1, and 3700 to 3100 cm-1 during turnover and inhibition. 
Upon thorough examination of each region of the RIFT-IR spectra collected, two 
unique features presented themselves in the regions from 2200 to 1800 cm-1 and 1160 to 
1000 cm-1. In Figure 3.11, 22 mixing experiments with ATP/CDP and HU (Figure 3.11 
D) exhibit a (+) 1872 cm-1 band not previously observed with control experiments 2 alone 
(Figure 3.11 A), 2 alone (Figure 3.11 B), or 2 with HU (Figure 3.11 C). After 
examination of other spectral ranges, it was also observed that controls showed no 
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contributions at the near IR in Figure 3.12 A-C. However, the mixing experiment in Figure 
3.12 D yielded a unique contribution at (–) 1040 cm-1. These new features were examined 
with other mixing experiments performed. Figure 3.13, presents data corresponding to 
22 mixing experiments performed in the presence and absence of HU. Figure 3.13 A 
contains 22 with ATP, CDP and HU. Figure 3.13 B contains 22 with ATP and CDP. 
Figure 3.13 C contains 22 with ATP, CDP and Fe(II)-3AP. Figure 3.13 D contains 22 
with TTP, UDP and HU. Figure 3.13 E contains 22 with TTP and UDP. Figure 3.13 F 
contains 22 with TTP and AzUDP. As observed in Figure 3.13, there is a unique band 
at 1872 cm-1. This signal is observed in mixing experiments which contain 22 with ATP 
and CDP and is present regardless of turnover or inhibition. In Figure 3.13 D, E and F, 
which contains 22 with TTP and UDP, there is no such signal to be observed in either 
case. Other inhibitors were analyzed for this same feature.  
In the near IR region from 1160 to 1000 cm-1, there is a similar distinction seen in 
the comparison of ATP/CDP vs TTP/UDP. In Figure 3.14 all spectra are displayed. Spectra 
A, B, and C correspond to ATP/CDP mixing spectra with HU, no inhibitor, and Fe(II)-
3AP, respectively. Spectra D, E, and F correspond to TTP/UDP (where applicable) mixing 
spectra with HU, no inhibitor, and AzUDP, respectively. In Figure 3.14 A-C, there is a 
negative band at 1040 cm-1 that is, again, present regardless of turnover or inhibition 
conditions. In Figure 3.14 D-F, there is no characteristic feature with TTP/UDP 
experiments under any condition.  
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Figure 3.13 Averaged α2β2 RIFT-IR spectra in the SD stretching region (A) 100 μM 
α2, 100 μM β2, 1 mM ATP, 3 mM CDP and 50 mM HU (B) 100 μM α2, 100 μM β2, 1 
mM ATP, 3 mM CDP (C) 100 μM α2, 100 μM β2, 1 mM ATP, 3 mM CDP and 40 μM 
Fe(II)-3AP (D) 100 μM α2, 100 μM β2, 0.8 mM TTP, 1 mM UDP, and 50 mM HU (E) 
100 μM α2, 100 μM β2, 0.8 mM TTP, 1 mM UDP (F) 100 μM α2, 100 μM β2, 0.8 mM 
TTP, 1 mM AzUDP. Tick marks for the spectra are 1 x 10-3 absorbance units. 
Averages: (A) 10 (B) 9 (C) 8 (D) 7 (E) 6 (F) 9. 
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Figure 3.14 Averaged α2β2 RIFT-IR spectra in the 1300 cm-1 IR region. (A) 100 μM 
α2, 100 μM β2, 1 mM ATP, 3 mM CDP and 50 mM HU (B) 100 μM α2, 100 μM β2, 1 
mM ATP, 3 mM CDP (C) 100 μM α2, 100 μM β2, 1 mM ATP, 3 mM CDP and 40 μM 
Fe(II)-3AP (D) 100 μM α2, 100 μM β2, 0.8 mM TTP, 1 mM UDP and 50 mM HU (E) 
100 μM α2, 100 μM β2, 0.8 mM TTP, 1 mM UDP (F) 100 μM α2, 100 μM β2, 0.8 mM 
TTP and 1 mM AzUDP. Tick marks for the spectra are 1 x 10-3 absorbance units. 
Averages: (A) 10 (B) 9 (C) 8 (D) 7 (E) 6 (F) 9. 
3.5 Discussion 
3.5.1 Summary.  
Illumination of how diverse substrate and effectors are able to regulate and maintain 
deoxynucleotides pools is fundamental in designing novel cancer therapeutics. Here we 
use reaction-induced FT-IR spectroscopy to highlight that the QC is conformationally 
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responsive and that these minute changes associated with binding to the enzyme are 
detectable and can be monitored as a function of time.  
3.5.2 Binding of effectors influence disordered secondary structure in the  subunit 
Previous studies focused on the assignment of contributions to the specific  or  
subunits when ATP and CDP are bound. 72 Table 3.1 summarizes the findings of this work 
to examine the influence of varying reactants. When TTP and UDP are incorporated into 
the QC, Figure 3.7 exhibits clear distinctions that begin to arise. Under turnover or 
inhibitory conditions, a band at 1706 cm-1 is observed that is not present with ATP and 
CDP and is most likely a conformational response of 2. In Figure 3.7, spectral features 
from 1686-1651 cm-1 are observed independent of experimental condition and are 
assignable to 2 as previously reported.72 These subtle changes in frequency are most 
likely due to small changes in the electrostatic environments as a result of larger 
conformational changes resulting from the varying of binding partners. TTP and UDP 
spectra no longer contain the (−) 1644 cm-1 band. This band was assigned to disordered 
regions of the  and  subunits when CDP and ATP operate as substrate and effector.84-85 
It is known that as different allosteric regulators bind to the 2 subunit, structural 
modifications impact ordered and disordered observed regions of the protein.18, 20  As 
reported on in cryo-EM studies, loop 2 contains several imperative residues for specificity 
site stability and recognition. TTP and UDP experiments retain (−) 1629, (−) 1584, and (+) 
1548 cm-1, while losing the positive 1527 cm-1, assignable to  sheets of the  subunit and 
amide II and asymmetric carboxylate bands. These extreme alterations seen in Figure 3.7 
C and D between these two spectra are most likely a result of conformational changes that 
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are occurring in the  loop 2 region. Further spectral contributions could be due to loops 1 
and 3 as a result of specificity site binding interactions. (Individual spectra of each of these 
conditions can be seen in Figures 3.15, 3.16, 3.18, and 19).  
3.5.3 Spectral contributions at 1872, 1040, and 1706 cm-1: sustainable regardless 
inhibition conditions.  
Based on the influence by substrate and effector binding resulting in changes to 
disordered structure, it stands to reason that these ordered structures would present 
distinctive features in RIFT-IR spectra about the inner workings of RNR turnover and 
inhibition. The peak at 1872 cm-1 that was observed with ATP and CDP was not present 
under any experimental condition measured with TTP and UDP. A typical S-H functional 
group appear from 2600-2500 cm-1 in FTIR spectroscopy for the stretching vibration. 
Exchange of the hydrogen with deuterium to produce S-D, typically results in a down shift 
to lower frequencies by approximately 700 cm-1 (1900-1820 cm-1) upon deuterium 
exchange in agreement with our 1872 cm-1 peak.86 To observe significant contributions, 
mixing experiments are performed in D2O so that functional groups are not washed out by 
water contribution. As laid out in chapter 1, the effector forms hydrogen bonds with 
Asp287 and Gly289 in loop 2. Binding of purine versus pyrimidine into the specificity site 
influences Gln288 to adopt either a “Gln-In” or “Gln-Out” position.20 The conformational 
dynamics associated with loop 2 which has a conserved cysteine (C292) has the potential 
to act as a sensor to perturbations occurring in the active and specificity sites. This 
interaction is the most likely explanation for a signal in this area. Other possible 
explanations would be the conserved active site cysteines (C225 and C462) and cysteines 
found on the exterior of the active site and function as a transfer system (C754 and C759). 
 119 
However, the presence of this unique band in Figure 3.13 is uninfluenced by any 
experimental parameter when ATP and CDP are present and is no longer detected when 
replaced by TTP and UDP under any variable. Therefore, this signal is attributed to the 
binding influence of the substrate or effector in the α2 subunit. Without additional controls, 
the assignment of the 1872 cm-1 signal cannot be definitely assigned to either subunit.  
Table 3.1 Assignment of amide region bands based on reaction-induced FT-IR 
spectroscopy, acquired in HEPES D2O buffer, pD 7.6. 






















1872 + + + − − − 2 Loop 2 
1706 − − − + + + 2 Loop 1-3 
1686 − + − + + + 2, β2 β-sheet/ side 
chain 
1672 + + + + + + 2 β-sheet 
1657 + + + + + + 2, β2 β-sheet /  -
helix 
1644 + + + − − − 2, β2 disordered 
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1635 + + + + − − 2, β2 Substrate 
consumption 
1620 − − + + − + 2, β2 β-sheet 
1613 + + + − − − 2 β-sheet 
1584 + + + + + + 2, β2 β-sheet 
1527 + + + − − − 2 β-sheet 
1514 + + + + + + β2 Y122OH 
1498 + + + + + + β2 Y122• 
1040 + + + − − − 2 Loop 2 
 
Upon examination of the near IR region in Figure 3.14, we also observed a negative 
band at 1040 cm-1 that is again observed when ATP or CDP are bound and not TTP and 
UDP. These signals lend further evidence to effector binding being the driving force for 
this new spectral contributions.18, 87 The specificity site in the  subunit consists of 
positively charged residues that intermingle with the negatively charged phosphates of the 
nucleotide. Because these experiments are performed in D2O, a deuterated cysteine signal, 
such as Cys292, in the low IR region is consistent with the signal at 1040 cm-1 due to the 
region being an indicator for S-H bending (1060 cm-1).88 The steric constraint of a purine 
bound in the active site demonstrates interactions not seen when the smaller pyrimidine, 
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TTP, is bound in the specificity site. Loop 2 associates with the effector leading to 
conformational rearrangement. Loop 2 is in contact with other nearby loops 1 and 3 that 
stabilize the phosphates of the bound effector. The position of one loop influences the 
position of each of the other loops leading to conformational cascade throughout the  
subunit ultimately facilitating communication with the substrate binding site.18 Inclusion 
of purine ATP leads to a conformational response that is not observable when TTP is bound 
to the specificity site.89-90  
In Figure 3.7 C and D, 1706 cm-1 is present under turnover in the 22/TTP/UDP 
and is uninfluenced by the incorporation of inhibitors. In Figure 3.7 A and B, this band is 
not detected in 22/ATP/CDP experiments. This band, as well as 1872 cm-1 and 1040 
cm-1, is attributable to never before seen conformational changes and hydrogen bonding by 
the 22 complex outside of x-ray crystallography. The loops surrounding the specificity 
site are highly variable and stabilized by the interaction with the bound effector. The QC 
exhibits small differences in response to inhibition by HU conceivably due to distinct 
conformational arrangements adopted in response to effectors. Mixing experiments with 
TTP, UDP, and HU exhibit the same amide I 1706 cm-1 signal (Figure 3.7 C), but also 
reveal positive peaks at 1626 and 1612 cm-1 and the loss of negative signals at 1644, 1629 
cm-1 and a positive amide II signal at 1527 cm-1 that were previously seen with ATP and 
CDP mixing experiments during turnover and inhibition (Figure 3.7 A and B). When TTP 
is bound, loops 1-3 adopt a more ordered structure that have defined positions, unlike its 
partially disordered structure when ATP is bound.18, 89-90 This structure gives rise to 
discrete peaks observed at 1872, 1706, and 1040 cm-1 regardless of experimental 
conditions.  
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3.5.4 Conformational Position of QC Displayed by Catalytic Site Radical Trap  
To this point, our investigation has been solely focused on examining the RNR 
under either turnover conditions or consequences resulting from quenching the tyrosyl 
radical with HU or Fe(II)-3AP. Observation of hydrogen bonding and conformational 
changes responsible for making radical transfer into the active site possible, is made even 
more difficult by the rapid speed at which the radical transfer process occurs and ultimately 
the enzyme masking the process altogether.2, 77 To overcome these obstacles, the use of a 
radical trap, AzidoUDP was implemented. This inhibitor traps the radical in the active site 
of the  subunit where it forms a nitrogen radical species.55-56, 68 This permits the detection 
of conformational changes that arise solely and specifically due to the forward PCET. In 
Figure 3.8 B, isolated 2 with TTP, UDP, and HU mixing experiments were performed as 
controls to monitor how substrate and effector influenced the spectra in an enzyme that is 
being actively reduced. This control was compared to 2 and HU alone, and the two spectra 
are nearly identical excluding a general broadening at 1610 cm-1 that was observed with 
TTP and UDP. In Figure 3.8 C, isolated 2 experiments with AzUDP shows no interaction 
like HU (Figure 3.8 A and B) nor should there be because there is no  subunit for AzUDP 
to interact with the radical. In Figure 3.6 B and D, UV-VIS spectroscopy exhibits loss of 
Y• when exposing the substrate analog to the active QC. In the QC, inhibition is presented 
that is unique from other inhibitory conditions. In Figure 3.8 F, the 1706 cm-1 signal is 
present again with AzUDP, in alignment with our assignment of TTP/UDP binding and 
existing with or without inhibitor. We also observe changes in the amide I region at (−)1657 
and (+) 1649 cm-1 consistent with the conserved radical pathway being conformationally 
active and secondary structure transformations during radical transfer into the active site. 
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Amide I (C=O) vibrational band characteristically appear in this region. This suggests that 
propagation of the hole to the active site, leaving Y122• reduced, is coupled with structural 
changes in the 2 subunit. Individual spectra show that for a third condition, the 1872 cm-
1 (Figure 3.13 F) and 1040 cm-1 (Figure 3.14 F) signals are not present when TTP is bound 
to the specificity site. Our previous work highlighted the Y122 residue undergoes a 
structural change during PCET, Y•→Y-OH,11 and there is potentially a second 
conformational active tyrosine, most likely Y356, during PCET.72 These experiments 
support these claims and probe the conformational dynamics associated with radical 
transfer into the active site causing the enzyme as a whole to be observed in a 
conformationally “locked,” structurally meaningful approach.  
3.5.5 Potent Radical Scavenger Alters the Secondary Structure of the QC.  
Finally, we explored another radical scavenging inhibitor comparable to HU. 
Triapine is a very effective RNR inhibitor. In Figure 3.6 A and C, UV-VIS spectroscopy 
demonstrates quenching of the tyrosyl radical in the QC by Fe(II)-3AP. In Figure 3.10, 
isolated 2 experiments show very similar modes of radical quenching by HU (Figure 3.10 
A) and Fe(II)-3AP (Figure 3.10 B) using 50mM HU and 40μM Fe(II)-3AP, but still 
displaying similar rates of inhibition. HU has no defined binding site or a particularly high 
affinity for RNR,91-92 which causes it to have devastating side effects.80 Figure 3.10 C and 
D compares the QC with the two radical scavenging inhibitors but yield vastly diverse 
spectra. There is a complete loss of the positive 1687 cm-1 band, an  subunit amide I 
contribution by  sheet or side chain,72 that was observed under HU inhibition with both 
ATP/CDP and TTP/UDP. This reinforces that the  subunit is in communication with the 
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 subunit and has a conformational response during inhibition. We also detected large 
negative characteristics at 1646, 1633, and 1624 cm-1. These mixing experiments involve 
ATP and CDP as substrate and effectors and we immediately see reformation of the 
disordered 1646 cm-1 band. The 1633 and 1624 cm-1 negative features could be a result of 
specific, and potentially multiple, binding locations for Fe(II)-3AP. These binding site(s) 
provide a cause as to why Triapine has such a high potency compared to other inhibitors 
and maintains a distinct spectrum from the other radical scavenger, HU. Inspection of the 
SD and low-IR regions provide the same unique signal for a third condition with ATP and 
CDP.  The bands at 1872 and 1040 cm-1 are present and again seem to be uninfluenced by 
inhibition and rely solely on the presence of ATP. In Figure 3.13 F, the spectrum illustrates 
the presence of the 1872 cm-1 band for the inhibitor Fe(II)-3AP, while Figure 3.14 F 
displays the negative band at 1040 cm-1. These bands, that are detected in the company of 
ATP and CDP, are detectable under turnover conditions and 2 separate types of inhibitors. 
In addition, these signals are not detected in the presence of TTP and UDP under turnover, 
inhibition by radical scavenging, or inhibition by radical trapping. The most likely 
explanation of these signals is the binding of ATP versus TTP to the specificity site which 
crystals structures have shown loop 2 of the  subunit to vary when the effector is.20 
However, the assignment of these features is not entirely clear. Uniformly, isotopically 
labeling both subunits will conclusively assign these features to the conformationally active 
Cys292 residue in the 2 subunit. 
3.6 Conclusion 
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 The conformational landscape of proteins provides an intricate quandary to 
decipher. FT-IR spectroscopy paired with radical activity allow us to untangle the dynamic 
conformational changes occurring during catalysis and inhibition. This technique allows 
for the observation of single amino acid changes taking place in this substantial enzyme. 
These experimental data begin to understand a host of natural processes in RNR that remain 
clouded. Understanding the conformational responsiveness of RNR to numerous substrates 
and effectors to maintain and regulate deoxynucleotides pools for DNA synthesis will 
mean understanding the regulatory controls for the enzyme itself. In the work presented, 
we have observed the enzymes conformational response to different allosteric effectors by 
the (−) 1644 cm-1 disordered region observed with ATP/CDP being absent with TTP/UDP. 
If this region is no longer disordered in TTP/UDP mixing experiments, then contributions 
should arise in another aspect of the spectra and could explain the appearance of the (+) 
1706 cm-1 peak that is observed with TTP/UDP. Advancing our knowledge of anti-cancer 
therapy interactions to include how they specifically interact with the protein is of vital 
importance. Determination of a single path or potentially multiple paths to inhibition will 
influence how drugs are designed, which are tested, and ultimately used as viable treatment 
options. HU and Fe(II)-3AP interact with isolated 2 in nearly identical routes to quench 
the tyrosyl radical but diverge in the assembled QC while still maintaining similar rates of 
reduction. Future work will aim to elucidate these two pathways further. The radical 
pathway has remained a fascinating enigma. Attempting to break down the radical 
progression into manageable phases (i.e. radical traps) to unbundle the biological 
procedures will provide a better understanding of such a vital process of life. We have 
presented exactly that with AzUDP. This radical trap illustrates clear coupling of 
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conformational dynamics to Y122• reduction. This work displays clear and dynamic 
structural perturbations associated with redox-linked structural changes in RNR.  
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3.8 Supporting Information 
As observed in Figure 3.2 B, FT-IR difference spectra were generated by 2 min of 
data collection, known as t1. The reaction was allowed to incubate for 6 min and then an 
additional 2 min of data was collected, t2. Data was subtracted (t1-minus-t2) to generate the 
difference spectra ( Abs) highlighting specific interactions due to either turnover or 
inhibition. This reaction scheme allows the direct monitoring of RIFT-IR spectroscopy to 
observe minimal baseline drift while maximizing Y122O• reduction. For the HU, Fe(II)-
3AP, and AzUDP (structures shown in figure 3.3 B-D) reactions, these difference spectra 
reflect radical state-minus-singlet state and 20-50% reduction of Y122O•. In Figure 3.15, 
we present RIFT-IR spectra recorded from α2β2 mixtures in the presence of ATP and CDP. 
In Figure 3.16, we present RIFT-IR spectra recorded from α2β2 mixtures in the presence 
of ATP, CDP, and HU. In Figure 3.17, we present RIFT-IR spectra recorded from α2β2 
mixtures in the presence of ATP, CDP, and Fe(II)-3AP. In Figure 3.18, we present RIFT-
IR spectra recorded from α2β2 mixtures in the presence of TTP and UDP. In Figure 3.19, 
we present RIFT-IR spectra recorded from α2β2 mixtures in the presence of TTP, UDP, 
and HU. In Figure 3.20, we present RIFT-IR spectra recorded from α2β2 mixtures in the 
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presence of TTP and AzUDP. In Figure 3.21, we present FT-IR spectra recorded from 
isolated β2. The average spectrum is presented in black above the individual spectra shown 
in red. In Figure 3.22, we present RIFT-IR spectra recorded from isolated β2 in the 
presence of HU. The average spectrum is again presented in black above the individual 
spectra shown in red. The data in Figures 3.15-3.22 are individual spectra to display 
reproducibility. The letters denote different days of data acquisition as pointed out in the 
figure legend.  
The data in Figures 3.23-3.29 are individual spectra to display reproducibility. The 
letters denote different days of data acquisition as pointed out in the figure legend. In Figure 
3.25, this spectrum contains 22, ATP, and CDP with Fe(II)-3AP and the individual 
spectra (red) as well as the average (black) exhibit the same band at 1872 cm-1 that was 
previously observed with other spectra containing ATP and CDP. In Figure 3.28, 22, 
TTP with AzUDP, in agreement with other TTP/UDP spectra display no trace of this band. 
In Figure 3.29, isolated β2 controls were analyzed for the presence of the putative S-D 
1872 cm-1 band. 
The water region (3700 to 3100 cm-1) was surveyed to find discrepancies either 
between substrate and effector influence or turnover and inhibitory conditions. The region 
can be highly variable. Further investigation will be required in this region to gain 
meaningful data of either substrate and effector binding variances or the mechanism of the 
long range PCET pathway. 
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Figure 3.15 Individual α2β2 with ATP/CDP RIFT-IR spectra collected on the 
following date (A) 3/15/15 (B) 1/26/14 (C) 1/27/14 (D) 1/29/14 and were vertically offset 





Figure 3.16 Individual α2β2 with ATP/CDP and HU RIFT-IR spectra collected on the 
following date (A) 3/15/15 (B) 1/26/14 (C) 1/27/14 (D) 1/29/14 and were vertically offset 




Figure 3.17 Individual α2β2 with ATP/CDP and Fe(II)-3AP RIFT-IR spectra 
collected on the following date (A) 2/24/16 (B) 2/25/16 (C) 3/08/16 and were vertically 




Figure 3.18 Individual α2β2 with TTP/UDP RIFT-IR spectra collected on the 
following date (A) 6/09/15 (B) 6/17/15 (C) 8/26/15 (D) 9/16/15 and were vertically offset 




Figure 3.19 Individual α2β2 with TTP/UDP and HU RIFT-IR spectra collected on the 
following date (A) 6/09/15 (B) 6/17/15 (C) 8/26/15 (D) 9/16/15 and were vertically offset 




Figure 3.20 Individual α2β2 with TTP/AzUDP RIFT-IR spectra collected on the 
following date (A) 12/15/15 (B) 12/16/15 (C) 2/09/16 (D) 2/11/16 (E) 1/11/16 and were 




Figure 3.21 Isolated 100 μM β2 with no inhibitors present were vertically offset for 
comparison. (A) Average (shown in black) of individually collected spectra (B-H) 
Individual isolated β2 (shown in red). Dates that each sample was collected are as 
follows: (B) 3/15/13 (C) 7/05/13 (D) 7/09/13 (E) 7/10/13 (F) 11/08/13 (G) 1/25/13 (H) 




Figure 3.22 Isolated 100 μM β2 and 50 mM HU were vertically offset for comparison. 
Individual¬ spectra are shown in red. (A) Average (shown in black) of individually 
collected spectra (B-H) Individual isolated β2 (shown in red). Dates that each sample 
was collected are as follows: (B) 3/15/13 (C) 7/05/13 (D) 7/09/13 (E) 7/10/13 (F) 




Figure 3.23 Individual α2β2 with ATP/CDP RIFT-IR spectra in the SD region were 
collected on the following date (A) 3/15/15 (B) 1/26/14 (C) 1/27/14 (D) 1/29/14 and were 




Figure 3.24 Individual α2β2 with ATP/CDP and HU RIFT-IR spectra in the SD region 
were collected on the following date (A) 3/15/15 (B) 1/26/14 (C) 1/27/14 (D) 1/29/14 




Figure 3.25 (A) Average α2β2 with ATP/CDP and Fe(II)-3AP RIFT-IR spectrum 
(black). Individual α2β2 with Fe(II)-3AP RIFT-IR spectra in the SD region (red) were 
collected on the following date (B) 2/24/16 (C) 2/25/16 (D) 3/08/16 and were vertically 
offset for comparison. Tick marks for the spectra are 1 x 10-3 absorbance units. 
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Figure 3.26 Individual α2β2 with TTP/UDP mixing spectra in the SD region were 
collected on the following date (A) 6/09/15 (B) 6/17/15 (C) 8/26/15 (D) 9/16/15. Tick 
marks for the spectra are 1 x 10-3 absorbance units. 
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Figure 3.27 Individual α2β2 with TTP/UDP and HU mixing spectra in the SD region 
were collected on the following date (A) 6/09/15 (B) 6/17/15 (C) 8/26/15 (D) 9/16/15 




Figure 3.28 Individual α2β2 with TTP/AzUDP mixing spectra in the SD region were 
collected on the following date (A) 12/15/15 (B) 12/16/15 (C) 2/09/16 (D) 2/11/16 (E) 
1/11/16 and were vertically offset for comparison. Tick marks for the spectra are 1 x 
10-3 absorbance units. 
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Figure 3.29 Isolated β2 controls were vertically offset for comparison: (A) 40 μM β2, 
1 mM ATP, and 3 mM CDP (B) 40 μM β2, 1 mM ATP, 3 mM CDP, and 50 mM HU 
(C) 40 μM β2, 1 mM ATP, 3 mM CDP, and 40 μM Fe(II)-AP (D) 40 μM β2, 0.8 mM 
TTP, and 1 mM UDP (E) 40 μM β2, 0.8 mM TTP, 1 mM UDP, and 50mM HU (F) 40 
μM β2, 0.8 mM TTP, and 1 mM AzUDP. 
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Figure 3.30 Individual α2β2 with ATP/CDP spectra in the water region were 
vertically offset and collected on the following date (A) 3/15/15 (B) 1/26/14 (C) 1/27/14 
(D) 1/29/14. Tick marks for the spectra are 2 x 10-3 absorbance units. 
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Figure 3.31 Individual α2β2 with ATP/CDP and HU spectra in the water region 
vertically offset and collected on the following date (A) 3/15/15 (B) 1/26/14 (C) 1/27/14 
(D) 1/29/14. Tick marks for the spectra are 2 x 10-3 absorbance units. 
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Figure 3.32 Individual α2β2 with ATP/CDP and Fe(II)-3AP spectra in the water 
region were vertically offset and collected on the following date (A) 2/24/16 (B) 2/25/16 





Figure 3.33 Individual α2β2 with TTP/UDP spectra in the water region vertically 
offset and collected on the following date (A) 6/09/15 (B) 6/17/15 (C) 8/26/15 (D) 





Figure 3.34 Individual α2β2 with TTP/UDP and HU RIFT-IR spectra in the water 
region vertically offset and collected on the following date (A) 6/09/15 (B) 6/17/15 (C) 
8/26/15 (D) 9/16/15. The spectra were offset along the y-axis for comparison. Tick 






Figure 3.35 Individual α2β2 with TTP/AzUDP spectra of the water region vertically 
offset and collected on the following date (A) 12/15/15 (B) 12/16/15 (C) 2/09/16 (D) 
2/11/16 (E) 1/11/16. Tick marks for the spectra are 2 x 10-3 absorbance units. 
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Figure 3.36 Individual isolated β2 controls in the water region were vertically offset 
for comparison: (A) 40 μM β2, 1 mM ATP, and 3 mM CDP (B) 40 μM β2, 1 mM ATP, 
3 mM CDP, and 50 mM HU (C) 40 μM β2, 1 mM ATP, 3 mM CDP, and   40 μM 
Fe(II)-AP (D) 40 μM β2, 0.8 mM TTP, and 1 mM UDP (E) 40 μM β2, 0.8 mM TTP, 1 
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CHAPTER 4.  SUMMARY 
4.1 Summary and future directions  
To summarize the work presented in this thesis, I have investigated the structure and 
utility of the active E. coli 22 complex upon binding of substrate and effectors. In 
addition to this, I have investigated the role that chemotherapeutics play in the isolated 2, 
where applicable, and the holoenzyme. Understanding the roles of these anti-cancer 
therapies and the conformational dynamics associated with their inhibition of the enzyme 
will aid in future drug design, to interact more specifically and be more potent, as well as 
elucidate the structural mechanisms surrounding RNR function.  In Chapter 2, we 
optimized time-resolved RIFT-IR spectroscopy to examine the structural effects of 22 
turnover with the effector ATP and the substrate CDP. Because RNR is such a high priority 
target for cancer therapies, the introduction of an inhibitor was used to observe quenching 
of the tyrosyl radical (Y122•→ Y122OH) by radical scavenger HU, which is a very widely 
study and characterized drug. The use of 13C isotopic labels in the  and  subunits enabled 
us to clarify spectral features as resulting from a specific subunit in the QC. In Chapter 3, 
I expanded on this work by examining the structural repercussions, if any, of replacing the 
effector TTP and the substrate CDP versus ATP/CDP. Furthermore, expanding on our 
therapies investigation, we expanded our inhibitors to include an additional radical 
scavenger similar to HU, Triapine, and a radical trap that behaves as a substrate analog, 
AzidoUDP. By expanding the numbers of inhibitors, it allowed me to explore two 
questions when it comes to the study of RNR. Firstly, do two drugs that are believed to 
inhibit similarly, quenching the tyrosyl radical in the resting state of the enzyme, have the 
 158 
same mechanism of inhibition when exposed to the enzyme under the same conditions. 
And secondly, will trapping the radical state in the active site of the  subunit reveal 
fundamental conformational dynamics associated with long-range proton-coupled electron 
transfer associated with radical transfer along the proposed hopping pathway. 
  In Chapter 2, we identified that the active complex could be observed in a 
physiological relevant turnover reaction. Not only could catalysis occur, but the production 
of dCDP could be observed by spectrophotometric assay. RIFT-IR spectra were acquired 
after mixing E. coli 2 and β2 with a substrate, CDP, and the allosteric effector, ATP.  
Isotopic chimeras, 13C2β2 and 213Cβ2, were used to describe subunit-specific 
conformational modifications observed in the difference spectra as amide I (C=O) and II 
(CN/NH) bands, derived from either the  or β subunit.  The addition of dATP resulted in 
a decreased contribution from amide I bands, attributable to beta strands and disordered 
structures. This result is expected as dATP has been shown to act as an inhibitor and been 
shown to be vital in forming the inactive complex, 4β4.  Most notably, HU-mediated 
reduction of Y122O• was associated with structural changes in 2, as well as β2. Control 
experiments with isolated 2 have shown no interaction with HU. This suggests that 2 is 
conformational responsive to the tyrosyl radical being quenched in the β2 subunit and 
ultimately suggests that there is some form of communication channel between the 
subunits. Contributions of Y122O•/Y122OH in the quaternary complex were examined by 
2H4 labeling of β2 tyrosines and HU-editing.  The bands of Y122O•, Y122OH, and D84, 
have been previously identified in isolated β2, were observed in the 2β2 complex.  These 
spectra also provide evidence for a conformational rearrangement at an additional β2 
tyrosine(s), Yx, in the 2β2/CDP/ATP complex, the most likely explanation being Y356.  
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In Chapter 3, I used RIFT-IR spectroscopy to describe the conformational 
landscape of the α2 subunit when diverse substrates and allosteric effectors are bound to 
the catalytic and specificity sites. The mechanism of inhibition by hydroxyurea (HU) and 
Fe(II)-Triapine (Fe(II)-3AP), two radical scavengers that inhibit α2β2. While specific 
proton donors have been proposed along the PCET pathway, conformational gating within 
homodimeric subunits has remained unclear, but with the use of radical trap 2′-azido-2′-
deoxyuridine 5′-diphosphate (AzUDP) conformational changes associated with the radical 
transition into the active site have been uncovered. RIFT-IR spectroscopy yielded amide I 
(C=O) and II (CN/NH) bands with catalytic and inhibitory conditions. The addition of the 
effector ATP/CDP, as opposed to TTP/UDP, resulted in the appearance of bands (+) 1872 
and (–) 1040 cm-1, likely due increased interactions between the conserved C292 in the 
specificity site, and, as a result, the enforced conformational response by loops 1 and 3. In 
the difference spectrum associated with the quenching of the tyrosyl radical by Fe(II)-3AP, 
the peak at (+) 1687 cm-1 previously assign to D84, a unidentate ligand to the differic 
cluster, is no longer present, but displays new negative features seen at (–) 1646, 1633, and 
1624 cm-1. AzUDP displays similarities at (+) 1685, 1674, and 1667 cm-1 with inhibition 
by HU, but also show bands at (+) 1657 and (–) 1649 cm-1 which have been assigned as 
contributions by D84 amide bond. I highlighted the utility by which reaction-induced FT-
IR spectroscopy is able to detect conformational changes in complex enzymes previously 
seen in x-ray crystallography. I revealed HU and Fe(II)-3AP interact with isolated β2 
similarly, but with the active complex in deviating processes to accomplish radical 
quenching. The distinctive inhibitor, AzUDP, reveals conformational changes 
accompanying long-range proton-coupled electron transfer (PCET) to demonstrate 
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backbone rearrangement associated with a redox-induced shift between Y122OH and D84 
in a functional α2β2 complex. 
There is still so much yet to learn about the mechanism of ribonucleotide reduction. 
The α2β2 enzyme displays distinct spectra when catalysis is occurring due to ATP and 
CDP versus when TTP and UDP are bound. Also, the method of inhibition by two radical 
quenchers and a radical trap in the active site of the α subunit exhibit discrete 
conformational responses during inactivation. To further clarify these newly discovered 
conformational changes, isotopic labeling of the α and β subunits would allow for specific 
assignment of these new spectral bands that have been observed in the α2β2 mixing 
experiments.  
Isotopic labeling of the α subunit will identify fundamental subunit responses to 
substrate and effector binding to the active and allosteric regulation sites, as well as redox-
linked physical changes in the α subunit. As described in chapter 3, there are two unique 
signals at (+) 1872 and (–) 1040 cm-1 that are observed when ATP and CDP are introduced 
to the α2 dimer and remain present regardless of under catalytic or inhibition conditions. 
Interestingly, these signals are no longer present when the substrate and effectors are 
changed to UDP and TTP, respectively. This band would be characteristic of an S–D band. 
By isotopically labeling the cysteine residue in the specificity site by an orthogonal 
tRNAse, and the unknown band is the proposed cysteine residue, the band would shift, 
which can be predicted by calculating the frequency based on the change in mass of the 
isotope compared to the natural abundance residue, the band would be identified. This 
experiment would inform the structural response by the α subunit when effectors are bound 
to the specificity site. If there is no shift by the band, the next likely explanation would be 
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the conserved cysteine residues in the active site. Another important isotopic labeling 
experiment would be labeling of Y730 and Y731. These two residues are conserved, and 
evidence has been provided to show that these residues are essential in the suggested 
radical hopping pathway. Previously, we have utilized global isotopic labeling residues of 
interest or the entire subunit as a whole. It was the unique environments of residues in the 
enzyme that allowed us to detect backbone residue shifts. Collaborators use an orthogonal 
tRNAse to specifically tag single amino acid residue. This technique would allow use to 
mark the individual tyrosine residues to observe conformational changes associated with 
long-range proton-coupled electron transfer. This experiment would provide much needed 
data about the α:β interface and the interactions between β-Y356 and α-Y31.  
By isotopically labeling the β2 homodimer, it would inform the PCET pathway, 
and changes centered around the diiron cluster responsible for radical generation. 
Inhibition by Fe(II)-3AP proved to have a vastly altered FTIR spectrum compared to HU. 
The tyrosyl radical gives a unique signal in the FTIR spectra, so by global labeling tyrosine 
residues, precise modifications to Y122 can be observed. When Fe(II)-3AP quenches the 
tyrosyl radical, the process of interaction between inhibitor and enzyme will have a wider 
range of understanding. This includes further evidence of a second conformationally active 
tyrosine in β2. Additionally, comparisons can be drawn to HU to determine the similarities 
in the mechanisms between inhibition, if any. When AzUDP is introduced to the QC, these 
isotopic labels would provide further evidence of formation of hydrogen bonding 
interactions between Y122 and D84 due to radical reduction. We have previously shown 
that the iron bound ligand, D84, forms a hydrogen bond to Y122 after reduction of the 
radical. An interesting future direction for this project would be labeling of the glutamate 
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residues in the β2 protein. There are 3 iron bound glutamate residues. These residues are 
both unidentate and bidentate ligands. The conformational responses by the iron cluster to 
radical reduction in both isolated and α2β2 mixing experiments is vital. Particularly, those 
responses associated with AzUDP. This experiment would describe the metallo-cofactor 
during forward PCET, mimicking the natural biological system. 
Class Ia RNR houses a tyrosyl radical, which was the first discovered biologically 
essential organic radical in any protein. To develop new drugs, information concerning the 
mechanism is critical. To obtain information, a more specific comprehension of the 
radical’s complete cycle must be achieved. Fourier transform infrared spectroscopy allows 
for the detection of single amino acid changes that take place as a result of RNR due to 
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